var title_f34_17_35088="Melioidosis osteomyelitis";
var content_f34_17_35088=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F75905&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F75905&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Melioidosis osteomyelitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 392px; height: 260px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chronic draining leg ulcer with underlying osteomyelitis due to melioidosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bart Currie, FRACP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_17_35088=[""].join("\n");
var outline_f34_17_35088=null;
var title_f34_17_35089="Lactating breast abscess with skin compromise";
var content_f34_17_35089=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F68502&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F68502&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lactating breast abscess with skin compromise",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 349px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    When the overlying skin is thinned or necrotic, the best procedure is incision and drainage.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael J Dixon, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_17_35089=[""].join("\n");
var outline_f34_17_35089=null;
var title_f34_17_35090="Multicentric reticulohistiocytosis";
var content_f34_17_35090=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F77307&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F77307&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Multicentric reticulohistiocytosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple papules are present on the hand of this patient with multicentric reticulohistiocytosis. Note the small papules involving the proximal and lateral nail folds.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_17_35090=[""].join("\n");
var outline_f34_17_35090=null;
var title_f34_17_35091="Chronic venous disease";
var content_f34_17_35091=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Chronic venous disease (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?34/17/35091/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/17/35091/contributors\" id=\"au4006\">",
"       Patrick C Alguire, MD, FACP",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/17/35091/contributors\" id=\"au4070\">",
"       Barbara M Mathes, MD, FACP, FAAD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?34/17/35091/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/17/35091/contributors\" id=\"se323\">",
"       Robert H Fletcher, MD, MSc",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?34/17/35091/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/17/35091/contributors\" id=\"de2771\">",
"       Kathryn A Collins, MD, PhD, FACS",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?34/17/35091?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      CHRONIC VENOUS DISEASE OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Chronic venous disease is a common disorder that affects the veins of the legs. Normally, these veins carry blood from the legs to the heart. Normal veins have a series of valves that open and close to direct blood flow from the surface of the legs to the deep veins and back to the heart; the valves also control the pressure in veins and capillaries on the legs' surface.",
"    </p>",
"    <p>",
"     If the valves within the veins fail to work properly, blood can flow backwards in the veins and pool in the legs. The pooled blood can increase pressure in the veins. This can cause problems that are mild (leg heaviness, aching, dilated or unsightly veins) or severe (swelling, skin color changes, rashes on the legs, recurrent skin infections and chronic ulcers). People who develop these symptoms are said to have chronic venous insufficiency.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      CHRONIC VENOUS DISEASE CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     There are several conditions than can cause the valves and veins to work improperly:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Any problem that increases pressure in the veins in the legs can stretch the veins. This can damage the valves, which leads to even higher pressures and worsened vein function.",
"      </li>",
"      <li>",
"       A clot in a vein will block blood flow back through the vein, which can increase pressures, often permanently damaging the vein or valves even after the clot has dissolved.",
"      </li>",
"      <li>",
"       Leg injury or surgery can damage the veins or valves.",
"      </li>",
"      <li>",
"       Increased body weight (eg, pregnancy, obesity) can increase pressure in the veins of the legs, and this can damage the veins and valves.",
"      </li>",
"      <li>",
"       The muscles in the legs play an important role in the circulation of blood, acting as a pump. Standing or sitting for prolonged periods without walking can decrease the movement of blood out of the legs and lead to increased pressures in the veins and pooling of blood.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      CHRONIC VENOUS DISEASE SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Chronic venous disease can cause painless widened veins, skin irritation, skin discoloration, itching, swelling, and skin ulcers. The legs may feel heavy, tired, or achy, usually at the end of the day or after prolonged standing. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/17/13592?source=see_link\">",
"      \"Clinical evaluation of lower extremity chronic venous disease\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Dilated veins",
"     </span>",
"     &nbsp;&mdash;&nbsp;The most frequent feature of venous disease is widening (dilation) of the veins. Dilated veins may appear as thin blue flares (",
"     <a class=\"graphic graphic_picture graphicRef54276 \" href=\"mobipreview.htm?16/10/16559\">",
"      picture 1",
"     </a>",
"     ) to much wider veins that appear as twisted and raised areas on the skin, which are called varicose veins (",
"     <a class=\"graphic graphic_picture graphicRef71564 \" href=\"mobipreview.htm?38/14/39150\">",
"      picture 2",
"     </a>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Edema",
"     </span>",
"     &nbsp;&mdash;&nbsp;Long-standing venous insufficiency can cause swelling (edema) in the ankles and lower legs (",
"     <a class=\"graphic graphic_picture graphicRef61706 \" href=\"mobipreview.htm?15/43/16050\">",
"      picture 3",
"     </a>",
"     ). Mild edema may only be found at the end of the day or it may be present all the time. The area around the ankle bones is often the first place that swelling is seen.",
"    </p>",
"    <p>",
"     However, edema can develop in people with other conditions, so this problem should be evaluated to determine the cause. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/53/32594?source=see_link\">",
"      \"Patient information: Edema (swelling) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Skin changes",
"     </span>",
"     &nbsp;&mdash;&nbsp;Pooling of blood and increased pressure in the veins can cause the skin to become red, and over several years, the skin may become tan or a reddish-brown color. The skin changes are initially noticeable around the ankle, but frequently occur over the shins and on the foot.",
"    </p>",
"    <p>",
"     The skin can also develop a type of inflammation that can cause itching, dryness, oozing fluid, scaling, open sores from scratching, and crusting or scabbing. Some people develop an area of intensely painful skin that turns red or brown, hard, and scar-like. This can occur suddenly or may develop after many years.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Venous ulcers",
"     </span>",
"     &nbsp;&mdash;&nbsp;Skin ulcers caused by chronic venous insufficiency are called venous ulcers. These are usually located low on the inner ankle. Venous ulcers can occur higher on the leg after an injury, but rarely higher than the knee. More than one ulcer may occur at a time. Venous ulcers are usually tender to touch, shallow, have a red appearance at the bottom, and occasionally ooze.",
"    </p>",
"    <p>",
"     Venous ulcers can recur or may not heal for months or years.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      CHRONIC VENOUS INSUFFICIENCY DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     You may be diagnosed with chronic venous disease or chronic venous insufficiency based upon your symptoms, including varicose veins, swelling in the legs, skin changes, or skin ulcers. Further testing (ultrasound) is often performed to look at vein valve function to identify if the problem is located in the superficial veins or the deep veins. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/43/33462?source=see_link\">",
"      \"Diagnostic evaluation of chronic venous insufficiency\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h1\">",
"      CHRONIC VENOUS DISEASE MANAGEMENT",
"     </span>",
"    </p>",
"    <p>",
"     Treatment of chronic venous insufficiency tries to reduce symptoms, edema (swelling), treat thickened, hardened tissues, and heal ulcers. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/41/32410?source=see_link\">",
"      \"Medical management of lower extremity chronic venous disease\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Leg elevation",
"     </span>",
"     &nbsp;&mdash;&nbsp;Simple elevation of the legs above heart level for 30 minutes three or four times per day can reduce edema and improve blood flow in the veins. Improving blood flow can speed healing of venous ulcers.",
"    </p>",
"    <p>",
"     Leg elevation alone may be the only treatment needed for people with mild venous disease, although additional treatments are usually needed in more severe cases. However, it may not be practical for some people to elevate their legs several times per day.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Exercises",
"     </span>",
"     &nbsp;&mdash;&nbsp;Foot and ankle exercises are often recommended to reduce symptoms. Pointing the toes and feet down and up several times throughout the day can help to pump blood up into the legs. This may be especially helpful for people who sit or stand for long periods.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Compression therapy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most experts consider compression therapy to be an essential treatment for chronic venous disease [",
"     <a class=\"abstract\" href=\"mobipreview.htm?34/17/35091/abstract/1,2\">",
"      1,2",
"     </a>",
"     ]. Compression stockings are suggested for anyone with chronic venous disease. People with more severe symptoms, such as severe edema, skin changes, or skin ulcers often need treatment with compression bandages.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h3\">",
"      Compression stockings",
"     </span>",
"     &nbsp;&mdash;&nbsp;Compression stockings gently compress the legs, which may improve blood flow in the veins by preventing backward flow through the veins of the legs.",
"    </p>",
"    <p>",
"     Effective compression stockings apply the greatest amount pressure at the ankle and gradually decrease the pressure up the leg. These stockings are available with varying degrees of compression.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Stockings with small amounts of compression can be purchased at pharmacies and surgical supply stores without a prescription.",
"      </li>",
"      <li>",
"       People with moderate to severe disease, those on their feet a lot, and those with ulcers usually require prescription stockings. A healthcare provider may take measurements for stockings, or may write a prescription for stockings and then have a surgical supply or specialty store take the necessary measurements.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Stockings are available in several heights, including knee-high, thigh-high, and pantyhose. Knee-high stockings are sufficient for most patients. Some stockings can cause skin irritation or pain, although proper measurement and fitting of the stockings can reduce the risk of discomfort.",
"    </p>",
"    <p>",
"     The following are tips for using compression stockings (",
"     <a class=\"graphic graphic_table graphicRef57705 \" href=\"mobipreview.htm?12/29/12764\">",
"      table 1",
"     </a>",
"     and",
"     <a class=\"graphic graphic_figure graphicRef81922 graphicRef53659 graphicRef80635 \" href=\"mobipreview.htm?15/36/15944\">",
"      figure 1A-C",
"     </a>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h3\">",
"      Intermittent pneumatic compression pumps",
"     </span>",
"     &nbsp;&mdash;&nbsp;Standard compression stockings may be less effective or difficult to use if you are very overweight or have a lot of edema. An alternative approach is the use of intermittent pneumatic compression (IPC) pumps [",
"     <a class=\"abstract\" href=\"mobipreview.htm?34/17/35091/abstract/3\">",
"      3",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     These devices consist of flexible plastic sleeves that encircle the lower leg; periodically the air chambers inflate and compress the leg, and then deflate. These are generally used for four hours per day.",
"    </p>",
"    <p>",
"     Similar to compression stockings, IPC pumps may be painful for some people.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h3\">",
"      Compression bandages",
"     </span>",
"     &nbsp;&mdash;&nbsp;People with severe symptoms, like severe edema, skin changes and ulcers may need to be treated with compression bandages. These are multilayer wraps placed on the leg by an experienced nurse or physician after any ulcers are covered.",
"    </p>",
"    <p>",
"     The bandages are usually changed once or twice a week and must stay dry. A cast bag or other plastic bag can be placed over the compression bandage while showering to keep it dry. The bandages should be removed and replaced if they become wet, either from water or from wound drainage.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Dressings",
"     </span>",
"     &nbsp;&mdash;&nbsp;Ulcers are usually covered with special dressings before putting on compression stockings or compression bandages. Dressings are used to absorb fluid oozing out of the wound, reduce pain, control odor, remove dead or infected cells, and help new skin cells to grow.",
"    </p>",
"    <p>",
"     Several types of dressings may be required for a venous ulcer.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h2\">",
"      Medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;A variety of medications have been used for chronic venous disease and venous ulcers.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Diuretics (water pills) remove fluid from the body but are usually not very useful with chronic venous disease. Venous disease is caused by a problem in the veins of the legs rather than an overload of fluid throughout the body. Patients with severe edema (swelling) may sometimes benefit from a few days of diuretics. (See",
"       <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/53/32594?source=see_link\">",
"        \"Patient information: Edema (swelling) (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Aspirin (300 to 325",
"       <span class=\"nowrap\">",
"        mg/day)",
"       </span>",
"       may speed the healing of ulcers.",
"      </li>",
"      <li>",
"       Antibiotics are only recommended when there is an infection.",
"      </li>",
"      <li>",
"       Horse chestnut seed extract reduces swelling and leg size in people with chronic venous insufficiency. It may be recommended for people who cannot tolerate compression therapy, usually at a dose of 300 mg twice daily. Horse chestnut seed extract is available as a dietary supplement and does not require a prescription. However, its production is not regulated, and the dose may vary from one pill or bottle to another.",
"      </li>",
"      <li>",
"       Hydroxyethylrutoside is a prescription medication available in Europe that can reduce leg volume, swelling, and other symptoms.",
"      </li>",
"      <li>",
"       Stasis dermatitis (irritation of skin resulting from swelling, pooled blood and increased pressure in the veins) usually responds to moisturizers. Sometimes, a steroid cream or ointment is needed to help with itching.",
"       <br/>",
"       <br/>",
"       Other creams and ointments (eg, triple antibiotic ointments like Neosporin), anti-itch products, and scented lotions should be avoided because there is a risk of developing an allergic rash (contact dermatitis) from these products.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Treatment of contact dermatitis",
"     </span>",
"     &nbsp;&mdash;&nbsp;Contact dermatitis is a skin reaction that occurs when an irritating or allergy-producing substance touches the skin. The reaction may occur on the legs or other areas of the body. Contact dermatitis is common in people with chronic venous disease treated with topical therapy. Treatment of contact dermatitis is discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/38/32354?source=see_link\">",
"      \"Patient information: Contact dermatitis (including latex dermatitis) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H19\">",
"     <span class=\"h1\">",
"      VEIN ABLATION TREATMENTS",
"     </span>",
"    </p>",
"    <p>",
"     Vein ablation treatments are treatments designed to destroy superficial veins with abnormal valve function. These treatments are usually reserved for people with symptoms that do not respond to the treatments described above. Veins are destroyed in one of three ways:",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Sclerotherapy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Sclerotherapy is a chemical ablation in which a substance is injected into the vein, causing the vein to collapse. This procedure is done in an office setting. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/12/13514?source=see_link\">",
"      \"Liquid and foam sclerotherapy techniques for the treatment of lower extremity veins\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      Radiofrequency or laser ablation",
"     </span>",
"     &nbsp;&mdash;&nbsp;Radiofrequency and laser ablation involve putting a special device into the abnormal vein. High energy is applied, which destroys the vein from the inside. The vein is not removed but it no longer functions. These procedures can be done with minimal anesthesia (no incisions) and are often performed in an office setting. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/17/13592?source=see_link\">",
"      \"Clinical evaluation of lower extremity chronic venous disease\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H22\">",
"     <span class=\"h2\">",
"      Vein ligation/stripping",
"     </span>",
"     &nbsp;&mdash;&nbsp;Vein ligation or stripping are surgical procedures requiring anesthesia. Veins are removed with many small incisions.",
"    </p>",
"    <p>",
"     Compression stockings are generally recommended following these ablation procedures (see",
"     <a class=\"local\" href=\"#H13\">",
"      'Compression stockings'",
"     </a>",
"     above).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H23\">",
"     <span class=\"h1\">",
"      SUMMARY",
"     </span>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Chronic venous disease is a problem that affects the veins of the legs. Normally, the leg veins carry blood back to the heart. In people with chronic venous disease, the veins do not work as well. This can cause blood to collect in the lower legs and feet.",
"      </li>",
"      <li>",
"       People with chronic venous disease often complain of legs that feel heavy, tired, or achy. These problems are more common at the end of the day or after standing for long periods. The lower feet and ankles may also become swollen.",
"      </li>",
"      <li>",
"       People who have chronic venous disease can develop more severe problems like skin infections, skin color changes, rashes, or sores that do not heal. These infections and sores can be difficult to treat, and sometimes require months or years to heal.",
"      </li>",
"      <li>",
"       The goal of treatment is to improve symptoms, reduce swelling and prevent skin infections.",
"      </li>",
"      <li>",
"       Treatments for swelling include propping up the legs when possible, wearing stockings that gently compress the ankles and lower legs, and performing foot and ankle exercises.",
"      </li>",
"      <li>",
"       Treatments for skin ulceration include special coverings for the area and antibiotics if there is an infection. Some people will need compression bandages to help ulcers heal.",
"      </li>",
"      <li>",
"       Antibiotic ointments or salves that are rubbed on the skin, anti-itch creams, and scented lotions are not recommended because these products can cause an allergic rash.",
"      </li>",
"      <li>",
"       Vein ablation treatments (sclerotherapy, laser or radiofrequency ablation or surgical stripping) can be considered in patients who have symptoms that not respond medical management.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H24\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27017111\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27017119\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?1/3/1075?source=see_link\">",
"      Patient information: Deep vein thrombosis (blood clots in the legs) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?20/42/21155?source=see_link\">",
"      Patient information: Swelling (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?40/47/41714?source=see_link\">",
"      Patient information: Varicose veins and other vein disease in the legs (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/32/24067?source=see_link\">",
"      Patient information: Pulmonary embolism (blood clot in the lungs) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/34/30242?source=see_link\">",
"      Patient information: Doppler ultrasound (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/16/21762?source=see_link\">",
"      Patient information: Superficial phlebitis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/32/30210?source=see_link\">",
"      Patient information: Vein ablation (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27017162\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/53/32594?source=see_link\">",
"      Patient information: Edema (swelling) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/38/32354?source=see_link\">",
"      Patient information: Contact dermatitis (including latex dermatitis) (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27017169\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/29/11735?source=see_link\">",
"      Classification of lower extremity chronic venous disorders",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/17/13592?source=see_link\">",
"      Clinical evaluation of lower extremity chronic venous disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/43/33462?source=see_link\">",
"      Diagnostic evaluation of chronic venous insufficiency",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/41/32410?source=see_link\">",
"      Medical management of lower extremity chronic venous disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/22/43365?source=see_link\">",
"      Pathophysiology of chronic venous disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23127?source=see_link\">",
"      Post-thrombotic (postphlebitic) syndrome",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/12/13514?source=see_link\">",
"      Liquid and foam sclerotherapy techniques for the treatment of lower extremity veins",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Heart, Lung, and Blood Institute",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nhlbi.nih.gov/\">",
"      www.nhlbi.nih.gov/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Venous Forum",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.veinforum.org/patients.aspx\">",
"      www.veinforum.org/patients.aspx",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?34/17/35091/abstract/1-4\">",
"      1-4",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 7, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?34/17/35091?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35091/abstract/1\">",
"      Douglas WS, Simpson NB. Guidelines for the management of chronic venous leg ulceration. Report of a multidisciplinary workshop. British Association of Dermatologists and the Research Unit of the Royal College of Physicians. Br J Dermatol 1995; 132:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35091/abstract/2\">",
"      Nelson EA, Bell-Syer SE, Cullum NA. Compression for preventing recurrence of venous ulcers. Cochrane Database Syst Rev 2000; :CD002303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35091/abstract/3\">",
"      Mani R, Vowden K, Nelson EA. Intermittent pneumatic compression for treating venous leg ulcers. Cochrane Database Syst Rev 2001; :CD001899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35091/abstract/4\">",
"      Callam MJ. Epidemiology of varicose veins. Br J Surg 1994; 81:167.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f34_17_35091=[""].join("\n");
var outline_f34_17_35091=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           CHRONIC VENOUS DISEASE OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           CHRONIC VENOUS DISEASE CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           CHRONIC VENOUS DISEASE SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           CHRONIC VENOUS INSUFFICIENCY DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H9\">",
"           CHRONIC VENOUS DISEASE MANAGEMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H19\">",
"           VEIN ABLATION TREATMENTS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H23\">",
"           SUMMARY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H24\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?42/27/43440\" title=\"figure 1A\">",
"           Putting on compression stockings PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?25/48/26368\" title=\"figure 1B\">",
"           Heel pocket out method PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?11/25/11664\" title=\"figure 1C\">",
"           Stocking donner PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          PICTURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?16/10/16559\" title=\"picture 1\">",
"           Spider veins ankle PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/14/39150\" title=\"picture 2\">",
"           Severe varicose veins PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?15/43/16050\" title=\"picture 3\">",
"           Pitting edema PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/29/12764\" title=\"table 1\">",
"           Tips for using compression stockings PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f34_17_35092="Duane syndrome type 1";
var content_f34_17_35092=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F76031&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F76031&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 527px\">",
"   <div class=\"ttl\">",
"    Duane syndrome of the left eye (type 1)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 507px; height: 349px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Notice the limitation of abduction. B) The very large up-shoot effect on attempted adduction. C) Upgaze is normal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Tasman W, Jaeger E. The Wills Eye Hospital Atlas of Clinical Ophthalmology, 2e. Lippincott Williams &amp; Wilkins, 2001. Copyright &copy;2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_17_35092=[""].join("\n");
var outline_f34_17_35092=null;
var title_f34_17_35093="CBD stone acute cholangitis";
var content_f34_17_35093=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F65633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F65633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Common bile duct stone",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 438px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gross specimen of a common bile duct stone in a patient with acute cholangitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert Odze, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_17_35093=[""].join("\n");
var outline_f34_17_35093=null;
var title_f34_17_35094="Choroid plexus cyst";
var content_f34_17_35094=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F74248%7EOBGYN%2F50051&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F74248%7EOBGYN%2F50051&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transverse image of the fetal head of an early second trimester fetus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 210px; height: 199px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The arrow demonstrates a unilateral choroid plexus cyst. The cyst is anechoic and surrounded by the more brightly echogenic choroid plexus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas D Shipp, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 599px\">",
"   <div class=\"ttl\">",
"    Multiple views of bilateral choroid plexus cysts",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 579px; height: 194px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ana Monteagudo, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_17_35094=[""].join("\n");
var outline_f34_17_35094=null;
var title_f34_17_35095="Quantifying sleepiness";
var content_f34_17_35095=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Quantifying sleepiness",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/17/35095/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/17/35095/contributors\">",
"     Neil Freedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/17/35095/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/17/35095/contributors\">",
"     Ruth Benca, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/17/35095/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/17/35095/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/17/35095/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to detect excessive sleepiness &mdash; defined as sleepiness that occurs in a situation when an individual would usually be expected to be awake and alert &mdash; because it is associated with morbidity and increased mortality, and can be treated in many cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/1\">",
"     1",
"    </a>",
"    ]. However, self-reported sleepiness is generally subjective and imprecise, which has led to the development of tests to quantify an individual's sleepiness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/2-5\">",
"     2-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The multiple sleep latency test (MSLT) and the maintenance of wakefulness test (MWT) use objective measures to quantify sleepiness. In contrast, the Epworth sleepiness scale (ESS) and Stanford sleepiness scale (SSS) subjectively quantify sleepiness. Other modalities used to assess sleepiness include the OSLER test and pupillometry.",
"   </p>",
"   <p>",
"    Here, the approach to quantifying sleepiness is described and each of the tests used to quantify sleepiness is discussed. A general approach to the epidemiology, etiology, clinical features and diagnosis of excessive daytime sleepiness is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/34/2600?source=see_link\">",
"     \"Approach to the patient with excessive daytime sleepiness\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following definitions are important for understanding the discussion that follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Epoch &mdash; An epoch is a standard 30 second duration of a polysomnogram (PSG) to which a sleep stage can be assigned. In special situations, an epoch can be longer or shorter.",
"     </li>",
"     <li>",
"      Sleep onset &mdash; Sleep onset is the beginning of the first epoch with greater than 15 seconds of cumulative sleep of any stage.",
"     </li>",
"     <li>",
"      Sleep latency &mdash; Sleep latency is the duration from lights out to the onset of sleep.",
"     </li>",
"     <li>",
"      Mean sleep latency &mdash; The mean sleep latency is the average of the sleep latencies determined during a test.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     GENERAL APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;A combination of subjective tests, objective tests, and clinical history are generally used to determine the degree of sleepiness. It is unknown which tests are best for quantifying sleepiness, and the roles of each are still being defined.",
"   </p>",
"   <p>",
"    In our clinical practice, we generally use the Epworth sleepiness scale (ESS) for initial assessment of sleepiness. We proceed to the multiple sleep latency test (MSLT) if:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The ESS or the patient's history identifies subjective sleepiness that seems out of proportion to objective findings from a polysomnogram (PSG), or",
"     </li>",
"     <li>",
"      The diagnosis of narcolepsy or idiopathic hypersomnia is being considered",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The MWT is primarily used in a research setting to assess an intervention's ability to improve alertness. Similarly, the SSS, OSLER test, and pupillometry are primarily research tools.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MULTIPLE SLEEP LATENCY TEST (MSLT)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The MSLT objectively measures an individual's tendency to fall asleep. It is based on the premise that individuals with a greater degree of sleepiness fall asleep faster than individuals with less sleepiness. The MSLT is considered the standard measurement of sleepiness and has proven to be a sensitive and reproducible test for quantifying sleepiness, regardless of the type of sleep deprivation (partial or complete, acute or chronic) or the underlying pathologic condition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/1,6-13\">",
"     1,6-13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The MSLT is part of the routine evaluation of patients who are suspected of having narcolepsy and may also be helpful in the evaluation of patients with suspected idiopathic hypersomnia. While the MSLT may support a diagnosis of narcolepsy or idiopathic hypersomnia, alone it is insufficient to confirm a diagnosis of either.",
"   </p>",
"   <p>",
"    A repeat MSLT may be warranted if the initial test was affected by inappropriate study conditions, ambiguous or uninterpretable, or failed to confirm narcolepsy despite strong clinical suspicion.",
"   </p>",
"   <p>",
"    The MSLT is not indicated as part of the routine evaluation of patients who are suspected of having excessive sleepiness due to obstructive sleep apnea (OSA, a disorder characterized by obstructive apneas and hypopneas), insomnia, circadian rhythm disorders, periodic limb movement disorder, medical disorders, or neurologic disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/1\">",
"     1",
"    </a>",
"    ]. In addition, it should not be performed to assess the effectiveness of therapy.",
"   </p>",
"   <p>",
"    The MSLT should not be used alone to evaluate the risk for driving, work, or home-related accidents because its validity for this purpose has not been proven [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/14\">",
"     14",
"    </a>",
"    ]. Instead, a combination of clinical history and the MSLT should guide clinical recommendations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Protocol",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important that the MSLT be performed as part of a standard protocol to minimize the many variables that can affect sleep latency, the test's primary measure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/1,6,8\">",
"     1,6,8",
"    </a>",
"    ]. A task force from the American Academy of Sleep Medicine (AASM) endorsed the following protocol:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stimulant, depressant, and REM suppressing medications (eg, antidepressants) should be discontinued at least two weeks (and preferably four weeks) prior to testing because they can impact the ability to fall asleep [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/15\">",
"       15",
"      </a>",
"      ]. In addition, other medications with stimulating or sedating side effects should be minimized.",
"     </li>",
"     <li>",
"      Patients should avoid vigorous physical activity, caffeinated beverages, and exposure to bright sunlight on the day of testing. When the patient arrives at the test center, drug testing may be indicated to confirm that sleepiness is not drug-induced.",
"     </li>",
"     <li>",
"      A PSG is performed prior to the MSLT, preferably during the patient's usual sleep period because the results may be affected by the phase of the individual's circadian clock [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/12,16,17\">",
"       12,16,17",
"      </a>",
"      ]. Smoking should stop at least 30 minutes prior to the PSG and other stimulating activities should cease at least 15 minutes prior to the PSG.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The purpose of the PSG prior to the MSLT is to objectively characterize the preceding sleep and to look for common causes of sleep fragmentation. The PSG must have confirmed at least six hours of sleep for the MSLT to be valid.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The MSLT begins 1.5 to three hours after the PSG. The patient is placed in a sleep-inducing environment and instructed to try to sleep. A sleep-inducing environment refers to a dark and quiet room with the room temperature based on the patient's comfort level. Monitoring includes electroencephalography (EEG), electrooculography, mental or submental electromyography, and electrocardiography.",
"     </li>",
"     <li>",
"      Each nap session continues for 15 minutes after sleep onset in order to detect REM sleep. The sleep latency is documented for each nap session. If the patient does not fall asleep, the nap session is terminated after 20 minutes and the sleep latency is documented as being 20 minutes.",
"     </li>",
"     <li>",
"      This is repeated at two hour intervals until the patient has had five opportunities to nap. Between nap sessions, the patient should be out of bed and encouraged to stay awake. Smoking should stop at least 30 minutes prior to each nap session and other stimulating activities should cease at least 15 minutes prior to each nap session. A shorter, four nap test may be performed, but this is unreliable for the diagnosis of narcolepsy unless two or more SOREMs have occurred. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/19/25913?source=see_link&amp;anchor=H376017#H376017\">",
"       \"Clinical features and diagnosis of narcolepsy\", section on 'Diagnostic evaluation'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary measure from the MSLT is the mean sleep latency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/1\">",
"     1",
"    </a>",
"    ]. This measure should be considered along with other clinical features (ie, subjective symptoms) when determining whether the mean sleep latency is clinically significant. Consider the two major indications for the MSLT, suspected narcolepsy or idiopathic hypersomnia:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A mean sleep latency of eight minutes or less, plus two or more sleep-onset rapid eye movements (SOREMs) support a diagnosis of narcolepsy in the appropriate clinical circumstances [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/1,18-20\">",
"       1,18-20",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/19/25913?source=see_link&amp;anchor=H376017#H376017\">",
"       \"Clinical features and diagnosis of narcolepsy\", section on 'Diagnostic evaluation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A mean sleep latency less than eight minutes, plus fewer than two sleep-onset rapid eye movements (SOREMs) support a diagnosis of idiopathic hypersomnia in the appropriate clinical setting [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There is no threshold mean sleep latency that, taken alone, can discriminate healthy individuals with normal (ie, expected) sleepiness from individuals with excessive sleepiness due to a sleep disorder. Previously, a mean sleep latency greater than ten minutes was considered normal and a mean sleep latency less than five minutes was considered abnormal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/1,6,8,18\">",
"     1,6,8,18",
"    </a>",
"    ]. These thresholds are no longer used because they discriminate poorly. Among the reasons that the MSLT discriminates poorly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Normal sleep latency has not been established. There are no large systematically collected data sets that include the mean sleep latency of healthy individuals. In addition, this information cannot be pooled from existing studies because variables that affect mean sleep latency differ among the studies, including the definition of sleep onset, the number of nap sessions, and the age of the patient population.",
"     </li>",
"     <li>",
"      There is a wide range of sleep latency even among healthy individuals. As a result, there is significant overlap in the sleep latency of normal individuals and individuals with sleep disorders.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When interpreting the MSLT, the clinician must be attentive to whether there was adherence to the protocol. Strict adherence to the protocol is required for valid and reliable results because the balance of sleep drive versus arousal influences measured sleepiness, and the protocol minimizes arousal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/1,8,22,23\">",
"     1,8,22,23",
"    </a>",
"    ]. One study evaluated healthy individuals who underwent the MSLT after either a five-minute walk or a 15-minute rest in bed while watching television [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/22\">",
"     22",
"    </a>",
"    ]. Sleep latencies were significantly increased in the group that walked prior to the MSLT, regardless of whether the individuals were sleep deprived.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Limitations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The MSLT may be unreliable when sleepiness is due to primary insomnia. Several studies have demonstrated that patients with primary insomnia have a mean sleep latency that is significantly longer than that of matched healthy controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/24-26\">",
"     24-26",
"    </a>",
"    ]. This reflects the difficulty that patients with insomnia have initiating sleep, rather than being an accurate measure of their sleepiness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/41/4758?source=see_link\">",
"     \"Overview of insomnia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another disadvantages of the MSLT is that it is time consuming (6.5 to 8.5 hours), labor intensive, and expensive to perform. Reducing the MSLT protocol to two or three naps is not an acceptable alternative. When this is done, the correlation coefficient for reproducibility of the mean sleep latency (over a four to fourteen month interval) is reduced from 0.97 to 0.85 for a three nap protocol and 0.65 for a two nap protocol [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     MAINTENANCE OF WAKEFULNESS TEST (MWT)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The MWT objectively measures the ability of an individual to remain awake for a defined period of time. It is based on the premise that individuals with a greater degree of sleepiness are less likely to remain awake than individuals with less sleepiness.",
"   </p>",
"   <p>",
"    The MWT should not be considered a substitute for the MSLT because the tests can give conflicting results, even when the same individual is given both tests on the same day [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/28\">",
"     28",
"    </a>",
"    ]. There are several possible reasons for conflicting results. The MWT and MSLT may measure different processes &mdash; the tendency to fall asleep (ie, the MSLT) and the ability to stay awake (ie, the MWT). Alternatively, the different directions given to the patient before each test and the different postures maintained during each test may affect the results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/23,29\">",
"     23,29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The MWT may be used to assess an individual's response to therapy. It is the direction of change, not the degree of change, that is meaningful in this situation because the degree of change that is clinically significant has not been established.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Protocol",
"    </span>",
"    &nbsp;&mdash;&nbsp;The MWT should be performed as part of a standard protocol. Using a protocol minimizes the variables that can impact sleep latency, the test's primary measure. Several acceptable protocols exist including the following, which was endorsed by a task force from the AASM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/1,3,30,31\">",
"     1,3,30,31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients should maintain their normal routine prior to the test. Upon arrival, they should be questioned to determine whether their sleep prior to the test was adequate in quality and quantity, and whether they feel alert. The MWT should be delayed if the patient reports suboptimal sleep or not feeling alert. A PSG is unnecessary.",
"     </li>",
"     <li>",
"      The MWT begins 1.5 to three hours after the patient's usual wake-up time. The patient is placed in a room with little or no external light. The only light source should be dim, slightly behind the patient's head, and just out of the patient's field of vision. The room temperature is based on the patient's comfort level. The patient sits upright in bed, with their back and head supported, and is instructed to try to stay awake as long as possible. Monitoring includes EEG, electrooculography, mental or submental electromyography, and electrocardiography.",
"     </li>",
"     <li>",
"      A session is ended after unequivocal sleep, or after 40 minutes if sleep does not occur. Sleep is considered unequivocal after three consecutive epochs of stage 1 sleep or one epoch of any other stage of sleep. For each session, the sleep latency is recorded. It is documented as being 40 minutes if the patient does not fall asleep.",
"     </li>",
"     <li>",
"      This is repeated every two hours, until the patient has completed four sessions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary measure from the MWT is the mean sleep latency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/1\">",
"     1",
"    </a>",
"    ]. There are few data regarding what constitutes a normal mean sleep latency, as measured by the MWT. Among healthy individuals who complete the four session, 40 minute protocol described above, the mean sleep latency is approximately 30 minutes, with greater than 97 percent of individuals having a mean sleep latency of eight minutes or greater [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/1\">",
"     1",
"    </a>",
"    ]. As a result, a mean sleep latency less than eight minutes is generally considered abnormal. Staying awake for at least 40 minutes during all four sessions is strong objective evidence that an individual can stay awake. A mean sleep latency between 8 and 40 minutes has uncertain significance.",
"   </p>",
"   <p>",
"    The relationship between MWT findings and driving risk are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/51/38710?source=see_link&amp;anchor=H4#H4\">",
"     \"Performance and safety risks of sleep deprivation and sleep disorders\", section on 'Sleep related breathing disorders'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Limitations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disadvantages of the MWT include its long duration and high cost. In addition, it is labor intensive. Although the MWT has been used to evaluate the risk for driving, work, or home-related accidents, its validity for this purpose has not been proven [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     EPWORTH SLEEPINESS SCALE (ESS)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ESS subjectively measures sleepiness as it occurs in ordinary life situations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/32\">",
"     32",
"    </a>",
"    ]. It can be used as a screening test for excessive sleepiness or to follow an individual's subjective response to an intervention.",
"   </p>",
"   <p>",
"    Eight situations are described on a questionnaire:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sitting and reading",
"     </li>",
"     <li>",
"      Watching television",
"     </li>",
"     <li>",
"      Sitting inactively in a public place",
"     </li>",
"     <li>",
"      Riding as a passenger in a car for one hour without a break",
"     </li>",
"     <li>",
"      Lying down to rest in the afternoon when circumstances permit",
"     </li>",
"     <li>",
"      Sitting and talking with someone",
"     </li>",
"     <li>",
"      Sitting quietly after lunch without alcohol",
"     </li>",
"     <li>",
"      Sitting in a car as the driver, while stopped for a few minutes in traffic",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Each situation receives a score of zero to three, which is related to the likelihood that sleep will be induced:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      0 = would never doze",
"     </li>",
"     <li>",
"      1 = slight chance of dozing",
"     </li>",
"     <li>",
"      2 = moderate chance of dozing",
"     </li>",
"     <li>",
"      3 = high chance of dozing",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, the total ESS score can range from zero to 24, with higher scores correlating with increasing degrees of sleepiness (",
"    <a class=\"graphic graphic_table graphicRef77101 \" href=\"mobipreview.htm?40/20/41291\">",
"     table 1",
"    </a>",
"    )(",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?17/29/17874?source=see_link\">",
"     calculator 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A score greater than ten is consistent with excessive sleepiness. This threshold between normal and abnormal subjective sleepiness is derived from an observational study of 180 adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/32\">",
"     32",
"    </a>",
"    ]. The mean ESS score was approximately six among healthy adults, compared to 16 or greater among patients with narcolepsy, idiopathic hypersomnia, or moderate to severe OSA (defined as a respiratory disturbance index [RDI] greater than 15 events per hour).",
"   </p>",
"   <p>",
"    The ESS can be performed in the examination room or waiting room. It is relatively simple and generally takes only a few minutes to complete. It should be repeated at subsequent visits to assess for change.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Correlation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subjective sleepiness measured by the ESS appears to correlate moderately with objective sleep tendency. In the largest population based study, the increased risk of falling asleep during a four session MSLT was 30 percent and 69 percent in individuals with intermediate (ESS score six to 11) and high (ESS score &gt;12) subjective sleepiness, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/33\">",
"     33",
"    </a>",
"    ]. Despite this study, the strength of the correlation between the ESS and objective measures of sleepiness remains controversial due to conflicting small studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Early studies demonstrated strong correlation between the ESS and MSLT [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/32,37\">",
"       32,37",
"      </a>",
"      ]. This included a study that reported that a score derived from only three of the situations &mdash; sitting inactively in a public place, sitting quietly after lunch, and sitting in a car stopped for a few minutes &mdash; correlated well with mean sleep latency measured by the MSLT.",
"     </li>",
"     <li>",
"      More recent studies have found little or no correlation between the ESS and the MSLT [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/38-40\">",
"       38-40",
"      </a>",
"      ]. In addition, weak correlation and discordant results between the ESS and the MWT have been reported among patients with sleep apnea and narcolepsy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/4,5\">",
"       4,5",
"      </a>",
"      ]. Advocates for the viewpoint that the ESS correlates poorly with the MSLT and MWT hypothesize that the tests measure different aspects of sleepiness.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Advantages",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ESS is widely available, reliable for assessing subjective sleepiness, and can be performed easily and quickly.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Disadvantages",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ESS cannot be used on multiple occasions throughout the day and is not a good measure of short-term acute sleep loss. Although the ESS score tends to increase with the severity of OSA and most patients with moderate to severe OSA have an ESS score greater than ten, the ESS should not be used to screen for OSA because it is neither sensitive nor specific for this purpose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     STANFORD SLEEPINESS SCALE (SSS)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The SSS is the best validated subjective measure of sleepiness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/3,42\">",
"     3,42",
"    </a>",
"    ]. It is typically used as a research tool to measure the impact of short-term acute sleep loss on subjective sleepiness. During the SSS, one of seven statements is chosen that best describes an individual's level of sleepiness:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      1 = feeling active, vital, alert, wide awake",
"     </li>",
"     <li>",
"      2 = functioning at a high level, not at peak, able to concentrate",
"     </li>",
"     <li>",
"      3 = relaxed, awake, not at full alertness, responsive",
"     </li>",
"     <li>",
"      4 = a little foggy, not at peak, let down",
"     </li>",
"     <li>",
"      5 = fogginess, losing interest in remaining awake, slowed",
"     </li>",
"     <li>",
"      6 = sleepiness, prefer to be lying down, fighting sleep, woozy",
"     </li>",
"     <li>",
"      7 = almost in reverie, sleep onset soon, losing struggle to remain awake",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Individuals who choose the fourth, fifth, sixth, or seventh statement at a time when they should be feeling alert, may have excessive sleepiness.",
"   </p>",
"   <p>",
"    Advantages of the SSS are that it can be administered multiple times throughout the day and night and it correlates with standard measures of performance. In addition, it correlates well with acute total sleep deprivation (but, less well with chronic partial sleep deprivation). This may be related to an individual's perception of their ability to get used to chronic sleep loss.",
"   </p>",
"   <p>",
"    The major disadvantage of the SSS is its inability to differentiate sleep deprived normal subjects from individuals with sleep disorders. There also appears to be some discordance between gross behavioral indicators of sleep (eg, closed eyes) and the first and second choices [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/3\">",
"     3",
"    </a>",
"    ]. Finally, the SSS only conveys information about a patient's state of sleepiness at single points in time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     OSLER TEST",
"    </span>",
"    &nbsp;&mdash;&nbsp;The OSLER (",
"    <strong>",
"     O",
"    </strong>",
"    xford",
"    <strong>",
"     SLE",
"    </strong>",
"    ep",
"    <strong>",
"     R",
"    </strong>",
"    esistance test) test is a simplified version of the MWT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/43\">",
"     43",
"    </a>",
"    ]. It has been used as a surrogate for the MWT because it is less labor intensive.",
"   </p>",
"   <p>",
"    The primary difference between the OSLER test and the MWT is that the onset of sleep is detected behaviorally during the OSLER test, instead of by EEG criteria. Specifically, the individual sits in front of an LED screen that flashes light every three seconds and is told to touch a button every time the light flashes. Sleep is confirmed when seven consecutive flashes (21 seconds) occur without a response. This is the minimal duration that can define an epoch of sleep [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/44\">",
"     44",
"    </a>",
"    ]. The OSLER test has a sensitivity and specificity of 85 and 94 percent, respectively, for detecting sleep lasting more the three seconds [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The OSLER test is not common. It has been used to measure sleep tendency in healthy individuals, sleep deprived individuals, and patients with sleep apnea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/45\">",
"     45",
"    </a>",
"    ]. However, the studies were small and further testing is required to confirm its validity and reliability using larger samples with different diseases.",
"   </p>",
"   <p>",
"    Advantages of the OSLER test include its simplicity, low cost, and automatic reading (ie, the computer program can determine when the test is complete based on when the subject misses the seven consecutive flashes). In addition, there are relatively few technical requirements that personnel must master [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     PUPILLOMETRY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pupillometry refers to measurement of the pupil of the eye. The premise underlying its use in quantifying sleepiness is that pupil size and stability are inversely related to the degree of subjective sleepiness.",
"   </p>",
"   <p>",
"    Pupil size is determined by the balance of input from the sympathetic nervous system to the dilator muscles of the iris (eg, during arousal) and from the parasympathetic nervous system to the sphincter muscles of the iris (eg, during drowsiness) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/46\">",
"     46",
"    </a>",
"    ]. A well rested, alert individual is able maintain a stable pupil size without oscillation in total darkness for 15 minutes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/47\">",
"     47",
"    </a>",
"    ]. In contrast, sleep deprived individuals are unable to maintain a stable pupil size, which manifests as frequent pupillary oscillations. Patients must be free of any medications that may affect the parasympathetic or sympathetic pathways at the time of pupillometry.",
"   </p>",
"   <p>",
"    An observational study of 13 healthy individuals demonstrated a strong relationship between sleep deprivation, pupil size, and pupil stability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35095/abstract/48\">",
"     48",
"    </a>",
"    ]. Specifically, SSS scores increased, slow pupillary oscillations increased, and pupil diameter decreased during persistent sleep deprivation.",
"   </p>",
"   <p>",
"    Pupillometry is not widely used because the equipment is not readily available. Further research is necessary to determine its role in the assessment of excessive sleepiness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It is important to detect excessive sleepiness and its underlying cause because excessive sleepiness is associated with morbidity and increased mortality. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A combination of subjective tests, objective tests, and clinical history are generally used to determine the degree of sleepiness. It is unknown which tests are best for quantifying sleepiness. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'General approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In our clinical practice, we generally use the Epworth sleepiness scale (ESS) for initial assessment of sleepiness. We proceed to the multiple sleep latency test (MSLT) if the patient's ESS or clinical history detects subjective sleepiness that seems out of proportion to objective findings from a PSG and the diagnoses of narcolepsy or idiopathic hypersomnia are being considered. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'General approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The MSLT objectively measures an individual's tendency to fall asleep. It is part of the routine evaluation of patients who are suspected of having narcolepsy because it can detect both excessive sleepiness and sleep-onset rapid eye movements (SOREMs), essential features of narcolepsy. The MSLT may also be helpful in the evaluation of patients with suspected idiopathic hypersomnia. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Multiple sleep latency test (MSLT)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The maintenance of wakefulness test (MWT) objectively measures the ability of an individual to remain awake for a defined period of time. It is used in clinical trials to assess an individual's response to therapy. Its utility in clinical practice is unclear because its ability to accurately predict a sleepy individual's ability to work safely or to operate a motor vehicle safely has not been validated. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Maintenance of wakefulness test (MWT)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The ESS subjectively measures sleepiness as it occurs in ordinary life situations by scoring eight situations that are described on a questionnaire. The Stanford sleepiness scale (SSS) subjectively measures sleepiness by choosing one of seven statements that best describes an individual's level of sleepiness. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Epworth sleepiness scale (ESS)'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18\">",
"       'Stanford sleepiness scale (SSS)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The OSLER test and pupillometry are infrequent methods of measuring sleepiness that are currently only used in a research setting. The OSLER test is a simplified version of the MWT in which the onset of sleep is detected behaviorally instead of electroencephalographically. Pupillometry uses pupillary size as an indicator of sleepiness. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'OSLER test'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H20\">",
"       'Pupillometry'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/1\">",
"      Littner MR, Kushida C, Wise M, et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005; 28:113.",
"     </a>",
"    </li>",
"    <li>",
"     Kribbs N, Getsy J, Dinges D. Investigation and management of daytime sleepiness in sleep apnea. In: Sleeping and Breathing, Saunders N, Sullivan C (Eds), Marcel Dekker, New York 1993. p.575.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/3\">",
"      Mitler MM, Miller JC. Methods of testing for sleepiness [corrected]. Behav Med 1996; 21:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/4\">",
"      Sangal RB, Mitler MM, Sangal JM. Subjective sleepiness ratings (Epworth sleepiness scale) do not reflect the same parameter of sleepiness as objective sleepiness (maintenance of wakefulness test) in patients with narcolepsy. Clin Neurophysiol 1999; 110:2131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/5\">",
"      Sangal RB, Sangal JM, Belisle C. Subjective and objective indices of sleepiness (ESS and MWT) are not equally useful in patients with sleep apnea. Clin Electroencephalogr 1999; 30:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/6\">",
"      Carskadon MA, Dement WC, Mitler MM, et al. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986; 9:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/7\">",
"      Zwyghuizen-Doorenbos A, Roehrs T, Schaefer M, Roth T. Test-retest reliability of the MSLT. Sleep 1988; 11:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/8\">",
"      Thorpy MJ. The clinical use of the Multiple Sleep Latency Test. The Standards of Practice Committee of the American Sleep Disorders Association. Sleep 1992; 15:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/9\">",
"      Lumley M, Roehrs T, Asker D, et al. Ethanol and caffeine effects on daytime sleepiness/alertness. Sleep 1987; 10:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/10\">",
"      Carskadon MA, Dement WC. Nocturnal determinants of daytime sleepiness. Sleep 1982; 5 Suppl 2:S73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/11\">",
"      Levine B, Roehrs T, Stepanski E, et al. Fragmenting sleep diminishes its recuperative value. Sleep 1987; 10:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/12\">",
"      Carskadon MA, Dement WC. Multiple sleep latency tests during the constant routine. Sleep 1992; 15:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/13\">",
"      Richardson GS, Carskadon MA, Orav EJ, Dement WC. Circadian variation of sleep tendency in elderly and young adult subjects. Sleep 1982; 5 Suppl 2:S82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/14\">",
"      Strohl, K, Bonnie, R, Findley, L, et al. Sleep apnea, sleepiness and driving risk. American Journal of Respiratory and Critical Care Medicine 1999; 150:1463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/15\">",
"      Wyatt JK, Cajochen C, Ritz-De Cecco A, et al. Low-dose repeated caffeine administration for circadian-phase-dependent performance degradation during extended wakefulness. Sleep 2004; 27:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/16\">",
"      Clodor&eacute; M, Benoit O, Foret J, Bouard G. The Multiple Sleep Latency Test: individual variability and time of day effect in normal young adults. Sleep 1990; 13:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/17\">",
"      Czeisler CA, Zimmerman JC, Ronda JM, et al. Timing of REM sleep is coupled to the circadian rhythm of body temperature in man. Sleep 1980; 2:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/18\">",
"      Aldrich MS, Chervin RD, Malow BA. Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep 1997; 20:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/19\">",
"      Littner M, Johnson SF, McCall WV, et al. Practice parameters for the treatment of narcolepsy: an update for 2000. Sleep 2001; 24:451.",
"     </a>",
"    </li>",
"    <li>",
"     Narcolepsy with cataplexy. In: International classification of sleep disorders, 2nd Ed: Diagnostic and coding manual, American Academy of Sleep Medicine, Westchester, IL 2005. p.81.",
"    </li>",
"    <li>",
"     Narcolepsy with cataplexy. In: International classification of sleep disorders, 2nd Ed: Diagnostic and coding manual, American Academy of Sleep Medicine, Westchester, IL 2005. p.98.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/22\">",
"      Bonnet MH, Arand DL. Sleepiness as measured by modified multiple sleep latency testing varies as a function of preceding activity. Sleep 1998; 21:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/23\">",
"      Bonnet MH, Arand DL. Arousal components which differentiate the MWT from the MSLT. Sleep 2001; 24:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/24\">",
"      Bonnet MH, Arand DL. 24-Hour metabolic rate in insomniacs and matched normal sleepers. Sleep 1995; 18:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/25\">",
"      Stepanski E, Zorick F, Roehrs T, et al. Daytime alertness in patients with chronic insomnia compared with asymptomatic control subjects. Sleep 1988; 11:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/26\">",
"      Schneider-Helmert D. Twenty-four-hour sleep-wake function and personality patterns in chronic insomniacs and healthy controls. Sleep 1987; 10:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/27\">",
"      Stepanski E, Zorick F, Roehrs T, Roth T. Effects of sleep deprivation on daytime sleepiness in primary insomnia. Sleep 2000; 23:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/28\">",
"      Sangal RB, Thomas L, Mitler MM. Disorders of excessive sleepiness. Treatment improves ability to stay awake but does not reduce sleepiness. Chest 1992; 102:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/29\">",
"      Hartse KM, Roth T, Zorick FJ. Daytime sleepiness and daytime wakefulness: the effect of instruction. Sleep 1982; 5 Suppl 2:S107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/30\">",
"      Roehrs T, Zwyghuizen-Doorenbos A, Roth T. Sedative effects and plasma concentrations following single doses of triazolam, diphenhydramine, ethanol and placebo. Sleep 1993; 16:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/31\">",
"      Mitler MM, Walsleben J, Sangal RB, Hirshkowitz M. Sleep latency on the maintenance of wakefulness test (MWT) for 530 patients with narcolepsy while free of psychoactive drugs. Electroencephalogr Clin Neurophysiol 1998; 107:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/32\">",
"      Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/33\">",
"      Punjabi NM, Bandeen-Roche K, Young T. Predictors of objective sleep tendency in the general population. Sleep 2003; 26:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/34\">",
"      Johns MW. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res 2000; 9:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/35\">",
"      Miletin MS, Hanly PJ. Measurement properties of the Epworth sleepiness scale. Sleep Med 2003; 4:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/36\">",
"      Chervin RD. Epworth sleepiness scale? Sleep Med 2003; 4:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/37\">",
"      Johns MW. Sleepiness in different situations measured by the Epworth Sleepiness Scale. Sleep 1994; 17:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/38\">",
"      Benbadis SR, Mascha E, Perry MC, et al. Association between the Epworth sleepiness scale and the multiple sleep latency test in a clinical population. Ann Intern Med 1999; 130:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/39\">",
"      Chervin RD, Aldrich MS, Pickett R, Guilleminault C. Comparison of the results of the Epworth Sleepiness Scale and the Multiple Sleep Latency Test. J Psychosom Res 1997; 42:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/40\">",
"      Chervin RD, Aldrich MS. The Epworth Sleepiness Scale may not reflect objective measures of sleepiness or sleep apnea. Neurology 1999; 52:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/41\">",
"      Kapur VK, Baldwin CM, Resnick HE, et al. Sleepiness in patients with moderate to severe sleep-disordered breathing. Sleep 2005; 28:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/42\">",
"      Hoddes E, Zarcone V, Smythe H, et al. Quantification of sleepiness: a new approach. Psychophysiology 1973; 10:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/43\">",
"      Bennett LS, Stradling JR, Davies RJ. A behavioural test to assess daytime sleepiness in obstructive sleep apnoea. J Sleep Res 1997; 6:142.",
"     </a>",
"    </li>",
"    <li>",
"     Rechtschaffen A, Kales A. A manual of standardized terminology: techniques and scoring system for sleep stages of human subjects, Brain Info. Serv./Brain Res. Int., UCLA; NIH Publ. 2040, Los Angeles, CA 1968.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/45\">",
"      Priest B, Brichard C, Aubert G, et al. Microsleep during a simplified maintenance of wakefulness test. A validation study of the OSLER test. Am J Respir Crit Care Med 2001; 163:1619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/46\">",
"      Yoss RE, Moyer NJ, Hollenhorst RW. Pupil size and spontaneous pupillary waves associated with alertness, drowsiness, and sleep. Neurology 1970; 20:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/47\">",
"      Lowenstein, O, Feinberg, R, Lowenfeld, I. Pupillary movements during acute and chronic fatigue: a new test for the objective evaluation of tiredness. Invest Opthalmo 1963; 2:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35095/abstract/48\">",
"      Wilhelm B, Wilhelm H, L&uuml;dtke H, et al. Pupillographic assessment of sleepiness in sleep-deprived healthy subjects. Sleep 1998; 21:258.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7688 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-183.1.191.153-22FFA76FCA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_17_35095=[""].join("\n");
var outline_f34_17_35095=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      GENERAL APPROACH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MULTIPLE SLEEP LATENCY TEST (MSLT)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Protocol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Interpretation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Limitations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      MAINTENANCE OF WAKEFULNESS TEST (MWT)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Protocol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Interpretation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Limitations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      EPWORTH SLEEPINESS SCALE (ESS)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Correlation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Advantages",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Disadvantages",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      STANFORD SLEEPINESS SCALE (SSS)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      OSLER TEST",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      PUPILLOMETRY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/7688\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/7688|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?40/20/41291\" title=\"table 1\">",
"      Epworth sleepiness scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?17/29/17874?source=related_link\" title=\"calculator 1\">",
"      Calculator: Epworth Sleepiness Scale (ESS)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/34/2600?source=related_link\">",
"      Approach to the patient with excessive daytime sleepiness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/19/25913?source=related_link\">",
"      Clinical features and diagnosis of narcolepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/41/4758?source=related_link\">",
"      Overview of insomnia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/51/38710?source=related_link\">",
"      Performance and safety risks of sleep deprivation and sleep disorders",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_17_35096="Three columns of the thoracolumbar spine";
var content_f34_17_35096=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F79986&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F79986&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 614px\">",
"   <div class=\"ttl\">",
"    Three columns of the thoracolumbar spine",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 462px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Jankowitz BT, Welch WC, Donaldson III WF. Injuries to the spinal cord and spinal column. In: The Trauma Manual, 3rd ed, Peitzman AB (Ed), et al, Lippincott Williams &amp; Wilkins, Philadelphia, 2007. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_17_35096=[""].join("\n");
var outline_f34_17_35096=null;
var title_f34_17_35097="Surveillance and screening for autism spectrum disorders in primary care";
var content_f34_17_35097=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Surveillance and screening for autism spectrum disorders in primary care",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/17/35097/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/17/35097/contributors\">",
"     Carolyn Bridgemohan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/17/35097/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/17/35097/contributors\">",
"     Marilyn Augustyn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/17/35097/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/17/35097/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/17/35097/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autism spectrum disorders (ASD) are a group of biologically based neurodevelopmental disorders characterized by impairments in three major domains: socialization, communication, and behavior. The Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text Revision (DSM-IV-TR) categorizes these disorders under \"pervasive developmental disorders\" (PDD) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/1\">",
"     1",
"    </a>",
"    ]. These disorders include autistic disorder (classic autism, sometimes called early infantile autism, childhood autism, or Kanner's autism); Asperger disorder (also known as Asperger syndrome); and pervasive developmental disorder-not otherwise specified (PDD-NOS), including atypical autism.",
"   </p>",
"   <p>",
"    The rationale for autism surveillance and screening in primary care will be reviewed here. General developmental screening, autism-specific screening tests, and clinical features, diagnosis, and management of autism spectrum disorders are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/49/26394?source=see_link\">",
"     \"Developmental-behavioral surveillance and screening in primary care\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/1/14361?source=see_link\">",
"     \"Screening tools for autism spectrum disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=see_link\">",
"     \"Clinical features of autism spectrum disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/3/38969?source=see_link\">",
"     \"Diagnosis of autism spectrum disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/54/872?source=see_link\">",
"     \"Autism spectrum disorders in children and adolescents: Overview of management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Autism spectrum disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;The terms \"pervasive developmental disorders\" (PDD) and \"autism spectrum disorders\" (ASD) describe a heterogeneous group of neurodevelopmental disorders that have diverse etiologies but are characterized by constellations of symptoms involving impairments in reciprocal social interaction, communication, and behavior (specifically, stereotyped interests and activities) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. This group of disorders includes autistic disorder, Asperger disorder, and pervasive developmental disorder-not otherwise specified (PDD-NOS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. In the Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text Revision (DSM-IV-TR), pervasive developmental disorder includes these three autism spectrum disorders, as well as Rett disorder and childhood disintegrative disorder. Rett disorder is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/29/32218?source=see_link\">",
"     \"Rett syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Autistic disorder &ndash; The DSM-IV-TR provides specific criteria to diagnose autistic disorder (",
"      <a class=\"graphic graphic_table graphicRef72403 \" href=\"mobipreview.htm?29/6/29804\">",
"       table 1",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/1\">",
"       1",
"      </a>",
"      ]. High-functioning autism is the term used to describe individuals with autism and an intelligence quotient (IQ) &gt;70 (ie, borderline and above intelligence).",
"     </li>",
"     <li>",
"      Asperger disorder &ndash; The DSM-IV-TR provides specific criteria to diagnose Asperger disorder (",
"      <a class=\"graphic graphic_table graphicRef60599 \" href=\"mobipreview.htm?12/57/13212\">",
"       table 2",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/1\">",
"       1",
"      </a>",
"      ]. The diagnostic criteria for autistic disorder and Asperger disorder differ only in the absence of language impairment for Asperger disorder and the requirement of presence of symptoms before age three years for autistic disorder. In contrast to autistic disorder, individuals with Asperger disorder have better facility with the mechanics of verbal expression, higher levels of cognitive function, and greater interest in interpersonal social activity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,4\">",
"       2,4",
"      </a>",
"      ]. There is some controversy regarding whether Asperger disorder is a form of high-functioning autism or a separate disorder. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/20/15689?source=see_link\">",
"       \"Asperger disorder: Clinical features and diagnosis in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      PDD-not otherwise specified (PDD-NOS) &ndash; The term PDD-NOS is used to describe individuals who meet some, but not all, of the DSM-IV-TR criteria for autistic disorder (ie, atypical autism) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/1,2\">",
"       1,2",
"      </a>",
"      ]. Individuals may fall into this category because of late age of presentation, atypical symptoms, or subthreshold symptoms. In addition, some clinicians make an initial diagnosis of PDD-NOS in children younger than 36 months regardless of the number or severity of symptoms because diagnostic accuracy is lower in younger children.",
"     </li>",
"     <li>",
"      Rett disorder &ndash; Rett disorder is a neurodevelopmental disorder that occurs almost exclusively in females. Affected patients initially develop normally, then gradually lose speech and purposeful hand use sometime after 18 months of age. Most cases of Rett disorder result from mutations in the",
"      <em>",
"       MECP2",
"      </em>",
"      gene. Characteristic features of Rett disorder include deceleration of head growth (in contrast to acceleration of head growth, which occurs in other ASD), stereotypic hand movements, and dementia. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/29/32218?source=see_link&amp;anchor=H7#H7\">",
"       \"Rett syndrome\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Childhood disintegrative disorder &ndash; The essential feature of childhood disintegrative disorder (CDD), which is extremely rare, is a marked regression in multiple areas of functioning following a period of at least two years of apparently normal development. Apparently normal development is reflected in age-appropriate verbal and nonverbal communication, social relationships, play, and adaptive behavior. After the first two years of life (but before age 10 years), the child has a clinically significant loss of previously acquired skills in at least two of the following areas: expressive or receptive language, social skills or adaptive behavior, bowel or bladder control, play, or motor skills. Once symptoms develop, children with CDD have developmental profiles that are essentially identical to children with autistic disorder. CDD is often associated with an identified organic condition (eg, seizures, metabolic disorder, etc).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Surveillance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surveillance is a process through which potential risk factors for developmental and behavioral disorders can be identified. It is defined as a flexible, continuous process in which knowledgeable professionals perform skilled observations of children during child health-care visits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. It is described in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/49/26394?source=see_link&amp;anchor=H2#H2\">",
"     \"Developmental-behavioral surveillance and screening in primary care\", section on 'Definitions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Screening is defined as a brief, formal, standardized evaluation, the purpose of which is the early identification of patients with unsuspected deviations from normal. A screening instrument enables detection of",
"    <span class=\"nowrap\">",
"     conditions/concerns",
"    </span>",
"    that may not be readily apparent without screening. Screening does not provide a diagnosis; it helps determine whether additional investigation (eg, a diagnostic evaluation) by clinicians with special expertise in ASD is necessary. Effective screening requires that results from standardized screening tests be considered in conjunction with clinical judgment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/49/26394?source=see_link&amp;anchor=H9#H9\">",
"     \"Developmental-behavioral surveillance and screening in primary care\", section on 'How to provide evidence-based surveillance and screening'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The United States Centers for Disease Control and Prevention (CDC), in collaboration with the American Academy of Pediatrics (AAP), initiated the \"Learn the Signs. Act Early\" campaign and developed the autism ALARM initiative to promote improved surveillance and screening for ASD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2\">",
"     2",
"    </a>",
"    ]. The five components of the mnemonic include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Autism is prevalent",
"     </li>",
"     <li>",
"      Listen to parents",
"     </li>",
"     <li>",
"      Act early",
"     </li>",
"     <li>",
"      Refer",
"     </li>",
"     <li>",
"      Monitor",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Autism is prevalent",
"      </strong>",
"      &ndash; The estimated prevalence of autism is 1 in 50 to 1 in 500 children. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/37/4698?source=see_link&amp;anchor=H8#H8\">",
"       \"Terminology, epidemiology, and pathogenesis of autism spectrum disorders\", section on 'Epidemiology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Listen to parents",
"      </strong>",
"      &ndash; Early signs of autism often are present before 18 months of age and frequently are of concern to parents [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/7-10\">",
"       7-10",
"      </a>",
"      ]. Parents' concerns, as assessed using a standardized measure, correlate with development problems in young children [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/11-13\">",
"       11-13",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Early indicators'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/49/26394?source=see_link&amp;anchor=H12#H12\">",
"       \"Developmental-behavioral surveillance and screening in primary care\", section on 'Eliciting and addressing parents' concerns'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Act early",
"      </strong>",
"      &ndash; An autism-specific screening test should be performed anytime concerns regarding autism are raised during developmental surveillance (",
"      <a class=\"graphic graphic_table graphicRef63709 \" href=\"mobipreview.htm?40/41/41627\">",
"       table 3",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,14\">",
"       2,14",
"      </a>",
"      ]. In addition, the",
"      <a class=\"external\" href=\"file://pediatrics.aappublications.org/content/120/5/1183.full\">",
"       AAP",
"      </a>",
"      recommends that an autism-specific screening tool be used at 18 and 24 months of age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2\">",
"       2",
"      </a>",
"      ]. The American Academy of Neurology (AAN) recommends that children who fail developmental screening, especially in language and social streams, undergo autism-specific screening [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/14\">",
"       14",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/49/26394?source=see_link&amp;anchor=H12#H12\">",
"       \"Developmental-behavioral surveillance and screening in primary care\", section on 'Eliciting and addressing parents' concerns'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/1/14361?source=see_link\">",
"       \"Screening tools for autism spectrum disorders\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Refer",
"      </strong>",
"      &ndash; If the results of the autism-specific screen are positive, the child should be referred for specialty evaluation and intervention services [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,9\">",
"       2,9",
"      </a>",
"      ]. Referral for intervention services should not be delayed pending specialty evaluation or confirmation of diagnosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2\">",
"       2",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Referrals'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      <strong>",
"       Monitor",
"      </strong>",
"      &ndash; Once the diagnosis is made, children with autism and their families will need ongoing support and medical management [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,15\">",
"       2,15",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Monitoring and support'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     BACKGROUND",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Delayed diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surveys of families of children with autism spectrum disorders (ASD) indicate that the mean interval between onset of parental concerns and seeking professional help is approximately six months; the interval between medical attention and diagnosis is even longer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/7,8,16\">",
"     7,8,16",
"    </a>",
"    ]. Analysis of data from the Center for Disease Control and Prevention&rsquo;s (CDC) population-based surveillance system indicates that the average length of time between first documented evaluation and diagnosis was 13 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Screening for autism can be challenging for a number of reasons. These include the time constraints of a typical office visit, the vague nature of social developmental milestones, and the variability of the signs and symptoms of ASD in individual children. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical features of autism spectrum disorders\", section on 'Overview'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some of the factors that contribute to earlier diagnosis include the presence of significant language delay and atypical behaviors, such as hand flapping and toe walking [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Factors that may delay diagnosis include less severe symptoms, lack of continuity of care, hearing impairment, oversensitivity to pain, living in a rural area, black race, and lower socioeconomic status [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Early indicators",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of autism can be detected in children before three years of age. Prospective studies of children at risk for ASD and retrospective studies using home movies to examine the early development of children with autism have identified a number of early symptoms and signs of ASD that begin to emerge after six months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/20-31\">",
"     20-31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A systematic review of studies using home movies found that during the first year, the behaviors that were most consistently altered in children with autism, but not in typically developing children or in children with intellectual disability (mental retardation), were reduced response to name and reduced frequency of looking at faces [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/25\">",
"     25",
"    </a>",
"    ]. During the second year, the behaviors that were most consistently altered in children with autism, but not in the other groups, related to sharing experiences, interests, or attention with others. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical features of autism spectrum disorders\", section on 'Overview'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Findings from the retrospective studies were confirmed in a prospective evaluation of 25 infants (22 from a high-risk group and three from a low-risk group) who met criteria for ASD at age 36 months and 25 typically developing infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/26\">",
"     26",
"    </a>",
"    ]. At age six months, the rate of gaze to the examiner's face, vocalizations to others, and social smiles was similar among infants who subsequently developed ASD and typically developing infants. However, between 6 and 12 months, the rate of these social communication behaviors decreased in the infants who subsequently developed ASD and increased in typically developing infants; the difference between groups continued to increase until age 36 months.",
"   </p>",
"   <p>",
"    Other studies comparing autistic and typically developing children (some of which were prospective studies of children at risk for ASD) have demonstrated that problems with eye contact, orienting to one's name, joint attention, pretend play, imitation, nonverbal communication, and language development are measurable by 18 to 24 months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/14,20,24,28-36\">",
"     14,20,24,28-36",
"    </a>",
"    ]. These symptoms are stable in children from toddler to preschool and school age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/14,21,36\">",
"     14,21,36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Red flags",
"    </span>",
"    &nbsp;&mdash;&nbsp;Important early symptoms and signs of ASD include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,14,32,37\">",
"     2,14,32,37",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Parental concerns about deficits in social skills",
"     </li>",
"     <li>",
"      Parental concerns about deficits in language skills or behavior",
"     </li>",
"     <li>",
"      Parental concerns about frequent tantrums or intolerance to change",
"     </li>",
"     <li>",
"      Delayed language and",
"      <span class=\"nowrap\">",
"       social/communication",
"      </span>",
"      skills (",
"      <a class=\"graphic graphic_table graphicRef74400 \" href=\"mobipreview.htm?18/20/18763\">",
"       table 4",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      No babbling by 9 months",
"     </li>",
"     <li>",
"      No pointing or gestures by 12 months",
"     </li>",
"     <li>",
"      Lack of orientation to name by 12 months of age",
"     </li>",
"     <li>",
"      No single words by 16 months",
"     </li>",
"     <li>",
"      Lack of pretend or symbolic play by 18 months",
"     </li>",
"     <li>",
"      No spontaneous, meaningful (not repetitive or echolalic) two-word phrases by 24 months",
"     </li>",
"     <li>",
"      Any loss of any language or social skills at any age",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Benefits of surveillance/screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased public and professional awareness of ASD has led to an increased emphasis on the need for early identification. Early identification is an important step in optimizing outcome. Early identification facilitates earlier education planning, provisions for family support, management of family stress, and delivery of appropriate medical care and treatment of associated conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/14,22,23,38,39\">",
"     14,22,23,38,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Early identification also is critical to providing timely and accurate genetic counseling before the conception of a subsequent child [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/40\">",
"     40",
"    </a>",
"    ]. This is particularly true if a genetic condition associated with ASD is identified (eg, tuberous sclerosis complex) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=see_link\">",
"     \"Clinical features of autism spectrum disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Early intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no cure for ASD. However, there is a consensus that treatment must be individualized depending upon the specific strengths, weaknesses, and needs of the child and family [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/41\">",
"     41",
"    </a>",
"    ]. Early diagnosis and early intensive treatment have the potential to affect outcome, particularly with respect to behavior, functional skills, and communication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,22,42\">",
"     2,22,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is increasing evidence that intervention is more effective when initiated as early as possible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/15,43-46\">",
"     15,43-46",
"    </a>",
"    ]. The establishment of appropriate management strategies in the early years can help to minimize or even avoid subsequent behavioral problems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/15,47,48\">",
"     15,47,48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/54/872?source=see_link\">",
"     \"Autism spectrum disorders in children and adolescents: Overview of management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/1/4122?source=see_link&amp;anchor=H4#H4\">",
"     \"Autism spectrum disorders in children and adolescents: Behavioral and educational interventions\", section on 'Effectiveness'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     GUIDELINES FOR SURVEILLANCE AND SCREENING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both the American Academy of Pediatrics (AAP) and the American Academy of Neurology (AAN) have published guidelines for the evaluation and management of children with autism spectrum disorders (ASD) that include recommendations for screening and early diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,14,49,50\">",
"     2,14,49,50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In accordance with the AAN and AAP, we recommend routine developmental surveillance at every well-child visit; in addition, developmental screening tests should be administered regularly at the 9-, 18-, and 24- or 30-month visits, and when developmental concerns are raised [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,14,50\">",
"     2,14,50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/49/26394?source=see_link&amp;anchor=H18501566#H18501566\">",
"     \"Developmental-behavioral surveillance and screening in primary care\", section on 'When to perform developmental-behavioral screening'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We recommend that autism-specific screening be performed in children with delayed",
"    <span class=\"nowrap\">",
"     language/communication",
"    </span>",
"    milestones, regression in social or language skills, children with a sibling diagnosed with ASD, and in children whose parents, care provider, or clinician raise concerns regarding autism. We also suggest autism-specific screening in all children at 18 and 24 months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,14,49,50\">",
"     2,14,49,50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/1/14361?source=see_link\">",
"     \"Screening tools for autism spectrum disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One important aspect of early identification of ASD in the United States is the mandate to provide publicly funded special education and related services through the Education of All Handicapped Children Act (PL-94-142 and PL 99-457) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Autism-specific screening is not recommended by the National Screening Committee in the United Kingdom [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/51-53\">",
"     51-53",
"    </a>",
"    ]. The committee believes there is insufficient information about several important aspects of autism upon which to base recommendations for screening. Important aspects that need to be resolved include the reasons for variation in prevalence estimates, the natural history of ASD in children identified at an early age, the lack of a screening test suitable for population screening that has been fully validated, and evidence regarding the effectiveness of interventions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/54\">",
"     54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/37/4698?source=see_link&amp;anchor=H8#H8\">",
"     \"Terminology, epidemiology, and pathogenesis of autism spectrum disorders\", section on 'Epidemiology'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/1/14361?source=see_link\">",
"     \"Screening tools for autism spectrum disorders\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H12\">",
"     'Early intervention'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Screening tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest that children be screened for autism with an autism-specific tool. Autism-specific screening tools assess different domains of development than general developmental screening tools, and the two tools are complementary [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/55\">",
"     55",
"    </a>",
"    ]. However, early developmental screening tools that focus on communication skills may be helpful in early identification of ASD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Autism-specific screening tools that systematically incorporate items addressing the core symptoms of ASD should be used to screen for autism in primary care practice. An autism-specific screening tool should be used in children with delayed",
"    <span class=\"nowrap\">",
"     language/communication",
"    </span>",
"    milestones, in children who have a regression in social or language skills, children with a sibling diagnosed with ASD, and in children whose parents, care provider, or clinician raise concerns regarding autism, and in all children at 18 and 24 months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,14,49,50\">",
"     2,14,49,50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/1/14361?source=see_link\">",
"     \"Screening tools for autism spectrum disorders\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H9\">",
"     'Early indicators'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical features of autism spectrum disorders\", section on 'Overview'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Autism-specific screening tools that have been developed for use in young children include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The Checklist for Autism in Toddlers (CHAT) for children 18 to 24 months of age",
"     </li>",
"     <li>",
"      The Modified CHAT (M-CHAT) for children 16 to 30 months of age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/57\">",
"       57",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The Quantitative CHAT",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Among these, only the CHAT and M-CHAT have been evaluated on large populations of children in community samples. Screening tools for ASD in young children are described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/1/14361?source=see_link&amp;anchor=H7#H7\">",
"     \"Screening tools for autism spectrum disorders\", section on 'Tools for children &lt;3 years'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The Infant Toddler Checklist (ITC) for children 6 to 24 months is not specific for autism but screens for early communication delays, one of the core features of autism, and can be used in children younger than 16 months. It is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/1/14361?source=see_link&amp;anchor=H13#H13\">",
"     \"Screening tools for autism spectrum disorders\", section on 'Infant-Toddler Checklist'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although autism-specific screening is not explicitly recommended at individual well-child visits after age 24 months, screening is still indicated if the parents or clinician are concerned about the possibility of an ASD. Children with milder phenotypes, such as Asperger disorder, may pass autism screening at 18 and 24 months.",
"   </p>",
"   <p>",
"    Validated autism screening tools for older children include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Autism-Spectrum Quotient-Child (AQ-Child) for children age 4 to 11 years",
"     </li>",
"     <li>",
"      Autism Spectrum Screening Questionnaire (ASSQ) for children age 7 to 16 years with suspected Asperger disorder",
"     </li>",
"     <li>",
"      Childhood Autism Syndrome Test (CAST), formerly Childhood Asperger Syndrome Test, for children age 4 to 11 years",
"     </li>",
"     <li>",
"      Developmental Behaviour Checklist (DBC)-Autism Screening Algorithm and DBC-Early Screen for children age 4 to 18 years with intellectual disabilities",
"     </li>",
"     <li>",
"      The Social Communication Questionnaire (SCQ), formerly known as the Autism Screening Questionnaire, for children 4 years and older",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Among these, only the SCQ has been evaluated on large populations of children. The SCQ, ASSQ, and AQ-Child have been validated in community samples in at least one study. These screening tools are described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/1/14361?source=see_link&amp;anchor=H14#H14\">",
"     \"Screening tools for autism spectrum disorders\", section on 'Tools for preschool and school-age children'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/1/14361?source=see_link&amp;anchor=H17#H17\">",
"     \"Screening tools for autism spectrum disorders\", section on 'Tools for Asperger disorder and high-functioning autism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF CHILDREN WHO SCREEN POSITIVE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Parental education",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the primary care clinician is reasonably confident that the child has an autism spectrum disorder (ASD), it is helpful to provide the parents with educational materials to review before the comprehensive evaluation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Resources'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Referrals",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children who screen positive for ASD should be referred for developmental services, a comprehensive diagnostic evaluation and audiologic evaluation, and offered genetic counseling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,9\">",
"     2,9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/3/38969?source=see_link&amp;anchor=H2#H2\">",
"     \"Diagnosis of autism spectrum disorders\", section on 'Comprehensive evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a child screens positive for autism, he or she should be referred for developmental services without delay, even before confirmation of the diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,9,49\">",
"     2,9,49",
"    </a>",
"    ]. Clinical experience demonstrates that the earlier a child with ASD receives appropriate intervention, the better the long-term outcome. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Early intervention'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In the United States, intervention services are provided by Early Intervention if the child is younger than three years of age and by the public school system if the child is older than three years. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/49/26394?source=see_link&amp;anchor=H89189211#H89189211\">",
"     \"Developmental-behavioral surveillance and screening in primary care\", section on 'Early Intervention, special education, and other intervention services'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Core features of successful autism educational programs are discussed above. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Early intervention'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/1/4122?source=see_link&amp;anchor=H5#H5\">",
"     \"Autism spectrum disorders in children and adolescents: Behavioral and educational interventions\", section on 'Attributes of successful programs'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Diagnostic evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children who screen positive for ASD also should be referred for a comprehensive diagnostic evaluation, preferably by a team that has expertise in the diagnosis and management of ASD. The diagnostic evaluation should include a thorough history; physical examination; neurologic examination; and direct assessment of the child's social, language, and cognitive development. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/3/38969?source=see_link&amp;anchor=H2#H2\">",
"     \"Diagnosis of autism spectrum disorders\", section on 'Comprehensive evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Genetic counseling",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition, the family should be offered genetic counseling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,58\">",
"     2,58",
"    </a>",
"    ]. The prevalence of ASD in siblings of children with isolated ASD is 2 to 8 percent, at least five times greater than that in the general population. The risk of autism may be even higher if the child has a genetic condition associated with ASD. Siblings of children with ASD also may be at risk for other communication or cognitive problems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/59-63\">",
"     59-63",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/37/4698?source=see_link&amp;anchor=H10#H10\">",
"     \"Terminology, epidemiology, and pathogenesis of autism spectrum disorders\", section on 'Rate in siblings'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Medical evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The medical evaluation for the child who has a positive screen for ASD is discussed separately. The history and physical examination may be performed by the primary care provider or as part of the comprehensive diagnostic evaluation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/3/38969?source=see_link&amp;anchor=H2#H2\">",
"     \"Diagnosis of autism spectrum disorders\", section on 'Comprehensive evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children who screen positive for a developmental abnormality or ASD should have a hearing test and measurement of blood lead level to exclude hearing loss and lead poisoning as potential treatable etiologies for developmental problems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,53\">",
"     2,53",
"    </a>",
"    ]. In addition, children with ASD may have pica, or a preoccupation with licking nonfood items, and therefore may be at increased risk for lead poisoning [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/64\">",
"     64",
"    </a>",
"    ]. Periodic lead screening may be indicated if pica persists [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/14\">",
"     14",
"    </a>",
"    ]. Further medical evaluation, including genetic testing, is indicated once the diagnosis of ASD is confirmed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/49/26394?source=see_link&amp;anchor=H20#H20\">",
"     \"Developmental-behavioral surveillance and screening in primary care\", section on 'Failed screening test'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/19/44344?source=see_link\">",
"     \"Evaluation of hearing impairment in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/24/394?source=see_link\">",
"     \"Childhood lead poisoning: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children with language delay should undergo a comprehensive speech and language evaluation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,53\">",
"     2,53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/46/26343?source=see_link\">",
"     \"Evaluation and treatment of speech and language disorders in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Monitoring and support",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once a diagnosis of ASD is made, the child and his or her parents will need ongoing support and medical management [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,9,15,65\">",
"     2,9,15,65",
"    </a>",
"    ]. Parents should be provided with information about appropriate schools, respite facilities, parent groups, and other community-based support systems. Families will also need ongoing guidance regarding unconventional",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    unproven alternative therapies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,15,65\">",
"     2,15,65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/54/16234?source=see_link&amp;anchor=H11#H11\">",
"     \"Autism spectrum disorders in children and adolescents: Complementary and alternative therapies\", section on 'Counseling families'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Continuing medical management includes monitoring for the development of seizures, sleep problems, nutritional and gastrointestinal problems related to diet selectivity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/15,66\">",
"     15,66",
"    </a>",
"    ], and treatment of behavioral and emotional difficulties. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/54/872?source=see_link\">",
"     \"Autism spectrum disorders in children and adolescents: Overview of management\"",
"    </a>",
"    .) Siblings of children with ASD should be monitored for symptoms of ASD (",
"    <a class=\"graphic graphic_table graphicRef63709 \" href=\"mobipreview.htm?40/41/41627\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef74400 \" href=\"mobipreview.htm?18/20/18763\">",
"     table 4",
"    </a>",
"    ), language delay, learning difficulties, social problems, and symptoms of anxiety or depression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2,14\">",
"     2,14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/57/32665?source=see_link&amp;anchor=H8#H8\">",
"     \"Specific learning disabilities in children: Clinical features\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Families benefit from referral to community resources such as parent groups, advocacy programs, and respite and recreational services. In the United States, many states provide additional services to families of children with autism spectrum disorders (ASD) through the Department of Developmental Services (formerly Department of Mental Retardation) regardless of the child's cognitive functioning. Families may also qualify for Supplemental Security Income (SSI) benefits, depending on income level. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/5/27737?source=see_link&amp;anchor=H13#H13\">",
"     \"Children with special health care needs\", section on 'Title V of the Social Security Act'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Online resources for parents and providers include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Center for Disease Control and Prevention&rsquo;s (CDC) \"",
"      <a class=\"external\" href=\"file://www.cdc.gov/ncbddd/actearly/index.html\">",
"       Learn the Signs. Act Early",
"      </a>",
"      \" site",
"     </li>",
"     <li>",
"      The CDC&rsquo;s &ldquo;Learn the Signs. Act Early&rdquo;",
"      <a class=\"external\" href=\"file://www.cdc.gov/ncbddd/actearly/act/class.html\">",
"       autism case training curriculum",
"      </a>",
"     </li>",
"     <li>",
"      The CDC's",
"      <a class=\"external\" href=\"file://www.cdc.gov/ncbddd/autism/index.html\">",
"       Autism Information Center",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.autism-society.org/\">",
"       Autism Society of America",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.autismspeaks.org/\">",
"       Autism Speaks",
"      </a>",
"     </li>",
"     <li>",
"      The",
"      <a class=\"external\" href=\"file://www.autismspeaks.org/what-autism/video-glossary\">",
"       Autism Spectrum Disorders Video Glossary",
"      </a>",
"      , an online resource for parents and providers with video clips showing early red flags for autism",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.firstsigns.org/\">",
"       First Signs",
"      </a>",
"     </li>",
"     <li>",
"      The United Kingdom's",
"      <a class=\"external\" href=\"file://www.autism.org.uk/\">",
"       National Autistic Society",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://fcsn.org/index.php\">",
"       Federation for Children with Special Needs",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.aane.org/\">",
"       Asperger's Association of New England",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.ssa.gov/ssi/\">",
"       Supplemental Security Income",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.autismscreening.org/\">",
"       Autism Screening Tool Kit for Primary Care Providers",
"      </a>",
"      , with information about implementing autism screening in primary care practice",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?40/46/41699?source=see_link\">",
"       \"Patient information: Autism spectrum disorders (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The estimated prevalence of autism spectrum disorders (ASD) is 1 in 50 to 1 in 500 children. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/37/4698?source=see_link&amp;anchor=H8#H8\">",
"       \"Terminology, epidemiology, and pathogenesis of autism spectrum disorders\", section on 'Epidemiology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The average length of time between initial evaluation for concerns related to ASD and diagnosis of ASD is 13 months. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Delayed diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptoms of ASD usually are present by 18 to 24 months of age and remain stable through preschool and school age. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Early indicators'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Important early indicators of ASD include parental concerns about deficits in social skills, language skills, or behavior; parental concerns about frequent tantrums or intolerance to change; and delayed language and social skills (",
"      <a class=\"graphic graphic_table graphicRef74400 \" href=\"mobipreview.htm?18/20/18763\">",
"       table 4",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H9\">",
"       'Early indicators'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=see_link\">",
"       \"Clinical features of autism spectrum disorders\"",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      No babbling by 9 months",
"     </li>",
"     <li>",
"      No pointing or gestures by 12 months",
"     </li>",
"     <li>",
"      Lack of orientation to name by 12 months of age",
"     </li>",
"     <li>",
"      No single words by 16 months",
"     </li>",
"     <li>",
"      Lack of pretend or symbolic play by 18 months.",
"     </li>",
"     <li>",
"      No spontaneous, meaningful (not repetitive or echolalic), two-word phrases by 24 months",
"     </li>",
"     <li>",
"      Any loss of any language or social skills at any age",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Early identification facilitates earlier education planning, provisions for family support, management of family stress, and delivery of appropriate medical care and treatment of associated conditions. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Benefits of surveillance/screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Early identification is essential to ensure that children with ASD receive the intensive early intervention that clinical experience demonstrates is key for optimal outcome. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Early intervention'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Autism-specific screening should be performed in children with delayed",
"      <span class=\"nowrap\">",
"       language/communication",
"      </span>",
"      milestones, regression in social or language skills, children with a sibling diagnosed with ASD, and in children whose parents, care providers, or clinician raise concerns regarding autism. In addition, we suggest that autism-specific screening be performed in all children at 18 and 24 months of age (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Guidelines for surveillance and screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several autism-specific screening tools have been developed for use in young children. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/1/14361?source=see_link\">",
"       \"Screening tools for autism spectrum disorders\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We recommend that children who screen positive for ASD be referred as soon as possible for developmental services (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Intervention'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children who screen positive for ASD should undergo a comprehensive diagnostic evaluation, preferably by a team that has expertise in the diagnosis and management of ASD. Genetic counseling also may be indicated. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Referrals'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children who screen positive for a developmental abnormality or ASD should undergo hearing evaluation and measurement of blood lead level. Comprehensive speech and language evaluation is indicated for those with language delay. Additional medical testing will be indicated if the diagnosis of ASD is confirmed. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Medical evaluation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/3/38969?source=see_link&amp;anchor=H26#H26\">",
"       \"Diagnosis of autism spectrum disorders\", section on 'Additional evaluation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Parents of children who have been diagnosed with ASD should be provided with information regarding appropriate schools, respite facilities, parent groups, and other community-based support systems. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Monitoring and support'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H23\">",
"       'Resources'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     American Psychiatric Association. Pervasive Developmental Disorders. In: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR&reg;)., American Psychiatric Association, Washington, DC  p.70.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/2\">",
"      Johnson CP, Myers SM, American Academy of Pediatrics Council on Children With Disabilities. Identification and evaluation of children with autism spectrum disorders. Pediatrics 2007; 120:1183.",
"     </a>",
"    </li>",
"    <li>",
"     National Institutes of Mental Health. Autism spectrum disorders (pervasive developmental disorders). Available at: file://www.nimh.nih.gov/health/topics/autism-spectrum-disorders-pervasive-developmental-disorders/index.shtml (Accessed on January 26, 2012).",
"    </li>",
"    <li>",
"     Volkman F, Wiesner L. Autism and related disorders. In: Developmental-Behavioral Pediatrics, 4th ed, Carey WB, Crocker AC, Coleman WL, et al (Eds), Saunders Elsevier, Philadelphia 2009. p.675.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/5\">",
"      Dworkin PH. Detection of behavioral, developmental, and psychosocial problems in pediatric primary care practice. Curr Opin Pediatr 1993; 5:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/6\">",
"      Dworkin PH. British and American recommendations for developmental monitoring: the role of surveillance. Pediatrics 1989; 84:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/7\">",
"      Howlin P, Moorf A. Diagnosis in a survey of over 1200 patients in the UK. Autism 1997; 1:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/8\">",
"      Howlin P, Asgharian A. The diagnosis of autism and Asperger syndrome: findings from a survey of 770 families. Dev Med Child Neurol 1999; 41:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/9\">",
"      Zwaigenbaum L, Bryson S, Lord C, et al. Clinical assessment and management of toddlers with suspected autism spectrum disorder: insights from studies of high-risk infants. Pediatrics 2009; 123:1383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/10\">",
"      Ozonoff S, Young GS, Steinfeld MB, et al. How early do parent concerns predict later autism diagnosis? J Dev Behav Pediatr 2009; 30:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/11\">",
"      Glascoe FP. Early detection of developmental and behavioral problems. Pediatr Rev 2000; 21:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/12\">",
"      Glascoe FP. Can clinical judgment detect children with speech-language problems? Pediatrics 1991; 87:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/13\">",
"      Glascoe FP, Dworkin PH. The role of parents in the detection of developmental and behavioral problems. Pediatrics 1995; 95:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/14\">",
"      Filipek PA, Accardo PJ, Ashwal S, et al. Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology 2000; 55:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/15\">",
"      Myers SM, Johnson CP, American Academy of Pediatrics Council on Children With Disabilities. Management of children with autism spectrum disorders. Pediatrics 2007; 120:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/16\">",
"      De Giacomo A, Fombonne E. Parental recognition of developmental abnormalities in autism. Eur Child Adolesc Psychiatry 1998; 7:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/17\">",
"      Wiggins LD, Baio J, Rice C. Examination of the time between first evaluation and first autism spectrum diagnosis in a population-based sample. J Dev Behav Pediatr 2006; 27:S79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/18\">",
"      Mandell DS, Novak MM, Zubritsky CD. Factors associated with age of diagnosis among children with autism spectrum disorders. Pediatrics 2005; 116:1480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/19\">",
"      Mandell DS, Listerud J, Levy SE, Pinto-Martin JA. Race differences in the age at diagnosis among medicaid-eligible children with autism. J Am Acad Child Adolesc Psychiatry 2002; 41:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/20\">",
"      Charman T, Swettenham J, Baron-Cohen S, et al. Infants with autism: an investigation of empathy, pretend play, joint attention, and imitation. Dev Psychol 1997; 33:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/21\">",
"      Lord C, Risi S, DiLavore PS, et al. Autism from 2 to 9 years of age. Arch Gen Psychiatry 2006; 63:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/22\">",
"      Baird G, Charman T, Cox A, et al. Current topic: Screening and surveillance for autism and pervasive developmental disorders. Arch Dis Child 2001; 84:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/23\">",
"      Gray DE. Accommodation, resistance and transcendence: three narratives of autism. Soc Sci Med 2001; 53:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/24\">",
"      Baird G, Charman T, Baron-Cohen S, et al. A screening instrument for autism at 18 months of age: a 6-year follow-up study. J Am Acad Child Adolesc Psychiatry 2000; 39:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/25\">",
"      Palomo R, Belinch&oacute;n M, Ozonoff S. Autism and family home movies: a comprehensive review. J Dev Behav Pediatr 2006; 27:S59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/26\">",
"      Ozonoff S, Iosif AM, Baguio F, et al. A prospective study of the emergence of early behavioral signs of autism. J Am Acad Child Adolesc Psychiatry 2010; 49:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/27\">",
"      Thorsen KL, Goldberg WA, Osann K, Spence MA. Birthday and non-birthday videotapes: the importance of context for the behavior of young children with autism. J Autism Dev Disord 2008; 38:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/28\">",
"      Zwaigenbaum L, Bryson S, Rogers T, et al. Behavioral manifestations of autism in the first year of life. Int J Dev Neurosci 2005; 23:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/29\">",
"      Lord C. Follow-up of two-year-olds referred for possible autism. J Child Psychol Psychiatry 1995; 36:1365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/30\">",
"      Stone WL, Lee EB, Ashford L, et al. Can autism be diagnosed accurately in children under 3 years? J Child Psychol Psychiatry 1999; 40:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/31\">",
"      Bolton PF, Golding J, Emond A, Steer CD. Autism spectrum disorder and autistic traits in the Avon Longitudinal Study of Parents and Children: precursors and early signs. J Am Acad Child Adolesc Psychiatry 2012; 51:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/32\">",
"      Johnson CP. Recognition of autism before age 2 years. Pediatr Rev 2008; 29:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/33\">",
"      Dawson G, Munson J, Estes A, et al. Neurocognitive function and joint attention ability in young children with autism spectrum disorder versus developmental delay. Child Dev 2002; 73:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/34\">",
"      Landa R, Garrett-Mayer E. Development in infants with autism spectrum disorders: a prospective study. J Child Psychol Psychiatry 2006; 47:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/35\">",
"      Nadig AS, Ozonoff S, Young GS, et al. A prospective study of response to name in infants at risk for autism. Arch Pediatr Adolesc Med 2007; 161:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/36\">",
"      Landa RJ, Gross AL, Stuart EA, Faherty A. Developmental trajectories in children with and without autism spectrum disorders: the first 3&nbsp;years. Child Dev 2013; 84:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/37\">",
"      Filipek PA, Accardo PJ, Baranek GT, et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord 1999; 29:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/38\">",
"      Pinto-Martin J, Levy SE. Early Diagnosis of Autism Spectrum Disorders. Curr Treat Options Neurol 2004; 6:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/39\">",
"      Manning SE, Davin CA, Barfield WD, et al. Early diagnoses of autism spectrum disorders in Massachusetts birth cohorts, 2001-2005. Pediatrics 2011; 127:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/40\">",
"      Simonoff E. Genetic counseling in autism and pervasive developmental disorders. J Autism Dev Disord 1998; 28:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/41\">",
"      Maglione MA, Gans D, Das L, et al. Nonmedical interventions for children with ASD: recommended guidelines and further research needs. Pediatrics 2012; 130 Suppl 2:S169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/42\">",
"      Rutter M. Autism: its recognition, early diagnosis, and service implications. J Dev Behav Pediatr 2006; 27:S54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/43\">",
"      Volkmar F, Cook EH Jr, Pomeroy J, et al. Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. J Am Acad Child Adolesc Psychiatry 1999; 38:32S.",
"     </a>",
"    </li>",
"    <li>",
"     National Research Council. Educating Children with Autism, Committee on Educational Interventions with Autism, Lord C, McGee JP (Eds), National Academy Press, Washington, DC 2001.",
"    </li>",
"    <li>",
"     New York State Department of Health Early Intervention Program. Clinical practice guideline: The guideline technical report: Autism/Pervasive developmental disorders assessment and intervention for young children (age 0-3 years). Publication No. 4217, Albany, NY 1999.",
"    </li>",
"    <li>",
"     Dawson G, Osterling J. Early intervention in autism. In: The Effectiveness of Early Intervention, Guralnick MJ (Ed), Paul H Brookes Publishing Co, Baltimore 1997. p.307.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/47\">",
"      Howlin P. Practitioner review: psychological and educational treatments for autism. J Child Psychol Psychiatry 1998; 39:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/48\">",
"      Durand VM, Carr EG. Functional communication training to reduce challenging behavior: maintenance and application in new settings. J Appl Behav Anal 1991; 24:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/49\">",
"      Committee on Children With Disabilities. Role of the pediatrician in family-centered early intervention services. Pediatrics 2001; 107:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/50\">",
"      Council on Children With Disabilities, Section on Developmental Behavioral Pediatrics, Bright Futures Steering Committee, Medical Home Initiatives for Children With Special Needs Project Advisory Committee. Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening. Pediatrics 2006; 118:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/51\">",
"      Williams J, Brayne C. Screening for autism spectrum disorders: what is the evidence? Autism 2006; 10:11.",
"     </a>",
"    </li>",
"    <li>",
"     NHS Evidence. National Screening Committee policy-autism screening www.library.nhs.uk/screening/SearchResults.aspx?catID=1962 (Accessed on February 08, 2011).",
"    </li>",
"    <li>",
"     Scottish Intercollegiate Guideline Network. Assessment, diagnosis and clinical interventions for children and young people with autism spectrum disorders, a national clinical guideline, number 98. July 2007. www.sign.ac.uk/pdf/sign98.pdf (Accessed on February 08, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/54\">",
"      Al-Qabandi M, Gorter JW, Rosenbaum P. Early autism detection: are we ready for routine screening? Pediatrics 2011; 128:e211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/55\">",
"      Pinto-Martin JA, Young LM, Mandell DS, et al. Screening strategies for autism spectrum disorders in pediatric primary care. J Dev Behav Pediatr 2008; 29:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/56\">",
"      Pierce K, Carter C, Weinfeld M, et al. Detecting, studying, and treating autism early: the one-year well-baby check-up approach. J Pediatr 2011; 159:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/57\">",
"      Robins DL, Fein D, Barton ML, Green JA. The Modified Checklist for Autism in Toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders. J Autism Dev Disord 2001; 31:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/58\">",
"      Muhle R, Trentacoste SV, Rapin I. The genetics of autism. Pediatrics 2004; 113:e472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/59\">",
"      Bailey A, Palferman S, Heavey L, Le Couteur A. Autism: the phenotype in relatives. J Autism Dev Disord 1998; 28:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/60\">",
"      Stone WL, McMahon CR, Yoder PJ, Walden TA. Early social-communicative and cognitive development of younger siblings of children with autism spectrum disorders. Arch Pediatr Adolesc Med 2007; 161:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/61\">",
"      Schaefer GB, Mendelsohn NJ, Professional Practice and Guidelines Committee. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders. Genet Med 2008; 10:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/62\">",
"      Georgiades S, Szatmari P, Zwaigenbaum L, et al. A prospective study of autistic-like traits in unaffected siblings of probands with autism spectrum disorder. JAMA Psychiatry 2013; 70:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/63\">",
"      Messinger D, Young GS, Ozonoff S, et al. Beyond autism: a baby siblings research consortium study of high-risk children at three years of age. J Am Acad Child Adolesc Psychiatry 2013; 52:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/64\">",
"      Shannon M, Graef JW. Lead intoxication in children with pervasive developmental disorders. J Toxicol Clin Toxicol 1996; 34:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/65\">",
"      Rapin I. Autism. N Engl J Med 1997; 337:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35097/abstract/66\">",
"      Valicenti-McDermott M, McVicar K, Rapin I, et al. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J Dev Behav Pediatr 2006; 27:S128.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 589 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-02DD474397-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_17_35097=[""].join("\n");
var outline_f34_17_35097=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Autism spectrum disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Surveillance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      BACKGROUND",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Delayed diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Early indicators",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Red flags",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Benefits of surveillance/screening",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Early intervention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      GUIDELINES FOR SURVEILLANCE AND SCREENING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Screening tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      MANAGEMENT OF CHILDREN WHO SCREEN POSITIVE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Parental education",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Referrals",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Intervention",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Diagnostic evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Genetic counseling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Medical evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Monitoring and support",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/589\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/589|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/6/29804\" title=\"table 1\">",
"      DSM IV criteria autism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/57/13212\" title=\"table 2\">",
"      DSM IV criteria Asperger disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?40/41/41627\" title=\"table 3\">",
"      Signs of autism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?18/20/18763\" title=\"table 4\">",
"      Early signs of autism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/20/15689?source=related_link\">",
"      Asperger disorder: Clinical features and diagnosis in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/1/4122?source=related_link\">",
"      Autism spectrum disorders in children and adolescents: Behavioral and educational interventions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/54/16234?source=related_link\">",
"      Autism spectrum disorders in children and adolescents: Complementary and alternative therapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/54/872?source=related_link\">",
"      Autism spectrum disorders in children and adolescents: Overview of management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/24/394?source=related_link\">",
"      Childhood lead poisoning: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/5/27737?source=related_link\">",
"      Children with special health care needs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=related_link\">",
"      Clinical features of autism spectrum disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/49/26394?source=related_link\">",
"      Developmental-behavioral surveillance and screening in primary care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/3/38969?source=related_link\">",
"      Diagnosis of autism spectrum disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/46/26343?source=related_link\">",
"      Evaluation and treatment of speech and language disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/19/44344?source=related_link\">",
"      Evaluation of hearing impairment in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?40/46/41699?source=related_link\">",
"      Patient information: Autism spectrum disorders (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/29/32218?source=related_link\">",
"      Rett syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/1/14361?source=related_link\">",
"      Screening tools for autism spectrum disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/57/32665?source=related_link\">",
"      Specific learning disabilities in children: Clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/37/4698?source=related_link\">",
"      Terminology, epidemiology, and pathogenesis of autism spectrum disorders",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_17_35098="Overview of infected (mycotic) arterial aneurysm";
var content_f34_17_35098=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of infected (mycotic) arterial aneurysm",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/17/35098/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/17/35098/contributors\">",
"     Denis Spelman, MBBS, FRACP, FRCPA, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/17/35098/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/17/35098/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/17/35098/contributors\">",
"     John F Eidt, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/17/35098/contributors\">",
"     Joseph L Mills, Sr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/17/35098/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/17/35098/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/17/35098/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/17/35098/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 18, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;An aneurysm is an abnormal focal arterial dilation. Pre-existing aneurysms can become secondarily infected, but aneurysmal degeneration of the arterial wall can also be the result of infection which may be due to bacteremia or septic embolization, as in the case of mycotic aneurysm. The name mycotic aneurysm was coined by Osler to describe aneurysms associated with bacterial endocarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/1\">",
"     1",
"    </a>",
"    ]. These were noted to have the appearance of \"fresh fungus vegetations\"; however, the majority of mycotic aneurysms are caused by bacteria. Although some authors use the term &ldquo;mycotic&rdquo; to describe infected aneurysm regardless of etiology, we will limit the use of this term to those aneurysms that develop when material originating in the heart causes arterial wall infection and subsequently dilation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Aneurysms are classified into true and false or pseudoaneurysms. True aneurysms involve all three layers of the arterial wall (intima, media, and adventitia). A false or pseudo-aneurysm is a collection of blood or hematoma which has leaked out of the artery but is then confined by the surrounding tissue.",
"   </p>",
"   <p>",
"    Infected aneurysm is a serious clinical condition that is associated with significant morbidity and mortality. Treatment consists of antibiotic therapy combined with aggressive surgical debridement of the infected tissue and vascular reconstruction, as needed. Endovascular therapies may have a role in the treatment of ruptured infected aneurysm and the treatment of patients at prohibitive risk for open surgery.",
"   </p>",
"   <p>",
"    The pathogenesis, microbiology, clinical manifestations, diagnosis, and treatment of infected aneurysms will be reviewed. The diagnosis and management of noninfected aneurysms are discussed in separate topic reviews. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/39/29304?source=see_link\">",
"     \"Iliac artery aneurysm\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/63/3065?source=see_link\">",
"     \"Popliteal artery aneurysm\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38746?source=see_link\">",
"     \"Management of asymptomatic abdominal aortic aneurysm\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for infected aneurysm include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Arterial injury &ndash; Arterial injury is an important risk factor for an infected aneurysm. Artery injury resulting in infected femoral artery pseudoaneurysm is commonly due to intravenous drug use (self-inflicted), but iatrogenic mechanisms, such as invasive monitoring, percutaneous access for cardiac catheterization, or other peripheral interventions can also lead to infected aneurysm [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/3,4\">",
"       3,4",
"      </a>",
"      ]. Arterial injury may result from other mechanisms, such as gastrointestinal perforation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/5,6\">",
"       5,6",
"      </a>",
"      ], or peripheral nerve block [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/7\">",
"       7",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H20047200\">",
"       'Direct bacterial inoculation'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Antecedent infection &ndash; In a retrospective review, nearly half of 43 patients with an infected aortic aneurysm were found to have an antecedent infection that included pneumonia, cholecystitis, urinary tract infection, endocarditis, diverticulitis, soft-tissue infection, and osteomyelitis. In the pre-antibiotic era, the majority of infected aneurysms were due to endocarditis. More contemporary series identify endocarditis as the likely etiology in 17 to 29 percent of cases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/8,9\">",
"       8,9",
"      </a>",
"      ]. The rapid development of an infected aortic aneurysm associated with periodontal infection and oral surgery has also been reported [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/10-13\">",
"       10-13",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H20046986\">",
"       'Septic emboli (mycotic aneurysm)'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Impaired immunity &ndash; Immunosuppressive states predispose the patient to infection, which may present with atypical clinical features. Immunosuppressive disorders were found in 70 percent of patients with infected aneurysms in a review of 43 patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/14\">",
"       14",
"      </a>",
"      ]. Diabetes, alcoholism, chronic glucocorticoid therapy, chemotherapy, and malignancy have been identified as possible risk factors for infected aneurysm [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/14-18\">",
"       14-18",
"      </a>",
"      ]. Immune mechanisms may play a role in the development of infected aneurysm in a variety of other circumstances, such as in patients with cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/19\">",
"       19",
"      </a>",
"      ], cirrhosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/20\">",
"       20",
"      </a>",
"      ], those undergoing hemodialysis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/21\">",
"       21",
"      </a>",
"      ], following gastrointestinal endoscopy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/22\">",
"       22",
"      </a>",
"      ], post-transplant, those with HIV infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/23,24\">",
"       23,24",
"      </a>",
"      ], and following trauma or near drowning [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/25\">",
"       25",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H20047212\">",
"       'Bacteremic seeding'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Atherosclerosis &ndash; Patients with atherosclerosis, particularly the elderly, are at risk for bacteremic seeding of atheromatous plaques. (See",
"      <a class=\"local\" href=\"#H20047212\">",
"       'Bacteremic seeding'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8521624\">",
"    <span class=\"h2\">",
"     Pre-existing aneurysm",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pre-existing aneurysms are at risk for secondary infection due to bacteremia or spread from a contiguous infection. The prevalence of infection in a pre-existing aneurysm is low. In a study that cultured aortic tissue from patients undergoing elective aneurysm repair, positive cultures were obtained in 33 of 88 patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/26\">",
"     26",
"    </a>",
"    ]. Positive cultures were associated with subsequent infected grafts in three patients. However, the majority of patients with positive aortic cultures had no known negative sequelae. (See",
"    <a class=\"local\" href=\"#H20047212\">",
"     'Bacteremic seeding'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H20047224\">",
"     'Contiguous infection'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20047087\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20047200\">",
"    <span class=\"h2\">",
"     Direct bacterial inoculation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Direct inoculation of bacteria into the arterial wall can occur at the time of vascular injury. An arterial injury may be self-inflicted, iatrogenic, accidental, or due to assault (gunshot, stab). Infected pseudoaneurysm following arterial injury has become one of the most common forms of infected aneurysm. The femoral artery is the most commonly involved arterial site.",
"   </p>",
"   <p>",
"    Self-induced infected pseudoaneurysms are the result of injection drug abuse wherein users inadvertently inoculate themselves via dirty needles into the arterial wall (they are aiming for the adjacent veins), or a surrounding hematoma. Infected pseudoaneurysms of the common femoral artery are most common but infection involving the external iliac, carotid, and subclavian arteries have also been reported.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20047212\">",
"    <span class=\"h2\">",
"     Bacteremic seeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacteremic seeding of an existing intimal injury, atherosclerotic plaque, or pre-existing aneurysm can lead to arterial wall infection.",
"   </p>",
"   <p>",
"    The intima is normally highly resistant to infection, but when diseased, it allows bacteria to pass through it into deeper layers of the arterial wall. Once a local infection is established, suppuration, localized perforation, and pseudoaneurysm can result. The aorta is the most common location affected primarily since it is the most frequent site of atherosclerosis, but peripheral arteries can also be affected. Infected aneurysm can occur in the absence of significant atherosclerosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a similar manner, pre-existing aneurysms may become secondarily infected, which may predispose to rupture. In a study of 80 patients undergoing open aortic repair, a greater number of positive cultures were found in patients with ruptured aneurysms compared with asymptomatic and symptomatic aneurysms (38 versus 9 and 13 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/28\">",
"     28",
"    </a>",
"    ]. Rupture of abdominal aortic aneurysms is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/61/11225?source=see_link&amp;anchor=H53322839#H53322839\">",
"     \"Management of symptomatic (non-ruptured) and ruptured abdominal aortic aneurysm\", section on 'Introduction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20047224\">",
"    <span class=\"h2\">",
"     Contiguous infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;A focus of infection can extend to the arterial wall. Extension of a postoperative infection can lead to an infected aneurysm and has been described in the setting of appendectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/29\">",
"     29",
"    </a>",
"    ], cholecystectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/30\">",
"     30",
"    </a>",
"    ], colorectal surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/31,32\">",
"     31,32",
"    </a>",
"    ], as a result of pancreatic pseudocyst [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/33\">",
"     33",
"    </a>",
"    ], and following knee or hip replacement surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]. Extension of infection not related to surgery can also occur as seen in vertebral osteomyelitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/37-39\">",
"     37-39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20046986\">",
"    <span class=\"h2\">",
"     Septic emboli (mycotic aneurysm)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Septic embolic from the heart can occlude the vasa vasorum of the vessel or the vessel lumen leading to vascular wall infection and mycotic aneurysm formation. Because of their embolic nature, mycotic aneurysms are often multiple but they can also be solitary. Spontaneous resolution with antibiotic therapy for endocarditis has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/40-42\">",
"     40-42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mycotic aneurysms can develop anywhere, but are most commonly seen in the cerebral, splanchnic, or other peripheral vessels typically at arterial bifurcations. Mycotic aneurysms of coronary arteries have also been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood cultures are positive in 50 to 85 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. Organisms have been isolated from aneurysmal tissue in up to 76 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/28,44\">",
"     28,44",
"    </a>",
"    ]. In one case series, multiple organisms were isolated in 8 percent and no pathogen was identified in 25 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/8\">",
"     8",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Although bacteriologic patterns continue to evolve over time, the organisms with the greatest affinity for the arterial wall, Staphylococcus species (spp) and Salmonella spp, remain the most common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/46-48\">",
"     46-48",
"    </a>",
"    ]. Staphylococcus aureus is the most common pathogen reported in 28 to 71 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/8,44\">",
"     8,44",
"    </a>",
"    ]. In several reports of infected aneurysms, methicillin-resistant S. aureus (MRSA) predominates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/49-51\">",
"     49-51",
"    </a>",
"    ]. In one series of pre-existing aneurysms, Staphylococcus epidermidis was the most prevalent organism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/28\">",
"     28",
"    </a>",
"    ]. Infected aneurysm due to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    intermediate S. aureus (VISA) has also been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Salmonella is reported in 15 to 24 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/8,46\">",
"     8,46",
"    </a>",
"    ]. The diseased aorta appears to be vulnerable to Salmonella and this pathogen is frequently isolated in infected aneurysms due to bacteremic seeding of atherosclerotic plaque [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Streptococcus pneumoniae was a frequent etiology of infected aneurysms in the pre-antibiotic era, but became rare with the advent of penicillin; however, Streptococcus pneumoniae may be re-emerging as a cause of infected aneurysms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/54,55\">",
"     54,55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other gram-negative organisms are also associated with bacteremic seeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/31,56-58\">",
"     31,56-58",
"    </a>",
"    ]. In one study, although gram-positive organisms predominated, gram-negative organisms were seen in 35 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/58\">",
"     58",
"    </a>",
"    ]. In this study, gram-negative infections were associated with a higher incidence of aneurysm rupture (84 versus 10 percent) and mortality (84 versus 50 percent) compared with gram-positive organisms.",
"   </p>",
"   <p>",
"    Less common causes of infected aneurysm include Treponema pallidum and Mycobacterium spp [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/59-62\">",
"     59-62",
"    </a>",
"    ]. Syphilis (T. pallidum) once caused up to 50 percent of infected aneurysms. Tuberculosis is a rare cause of infected aneurysms and is most often due to erosion of peri-aortic lymph nodes into the aortic wall. One review of cases of infected aneurysm caused by Mycobacterium tuberculosis found only 41 cases between 1945 and 1999 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fungal arterial infections are also rare but may occur in patients with immune suppression, diabetes mellitus or following treatment of a disseminated fungal disease. Pathogens include Candida [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/64\">",
"     64",
"    </a>",
"    ], Cryptococcus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/65\">",
"     65",
"    </a>",
"    ], Aspergillus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/66\">",
"     66",
"    </a>",
"    ], and Pseudallescheria boydii [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many other organisms have also been reported to cause infected aneurysms including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Other gram-positive organisms (eg, nonpneumococcal Streptococcus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/67\">",
"       67",
"      </a>",
"      ], Clostridium [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/68\">",
"       68",
"      </a>",
"      ], Corynebacterium [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/69\">",
"       69",
"      </a>",
"      ], Rothia dentocariosa [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/70\">",
"       70",
"      </a>",
"      ], Listeria [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/71,72\">",
"       71,72",
"      </a>",
"      ], Lactococcus cremoris [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/73\">",
"       73",
"      </a>",
"      ]).",
"     </li>",
"     <li>",
"      Other gram-negative organisms (eg, Pseudomonas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/56\">",
"       56",
"      </a>",
"      ], Klebsiella [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/74\">",
"       74",
"      </a>",
"      ], E. coli [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/57\">",
"       57",
"      </a>",
"      ], Campylobacter [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/75,76\">",
"       75,76",
"      </a>",
"      ], Yersinia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/77,78\">",
"       77,78",
"      </a>",
"      ], Brucella [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/79,80\">",
"       79,80",
"      </a>",
"      ], Haemophilus influenzae [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/81\">",
"       81",
"      </a>",
"      ], Coxiella burnetii [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/82-85\">",
"       82-85",
"      </a>",
"      ], Acinetobacter [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/86\">",
"       86",
"      </a>",
"      ], and Burkholderia pseudomallei [melioidosis] [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/87-90\">",
"       87-90",
"      </a>",
"      ]).",
"     </li>",
"     <li>",
"      Anaerobes (eg, Bacteroides [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/91\">",
"       91",
"      </a>",
"      ]).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classic presentation of an infected aneurysm is a painful, pulsatile, and enlarging mass together with systemic features of infection, such as fever. This presentation is more likely to be found for infected aneurysms that are superficial in location (eg, common femoral artery). In one series of 52 infected aneurysms among intravenous drug users, a tender indurated mass was palpated in 92 percent of cases; these were pulsatile in 52 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/44\">",
"     44",
"    </a>",
"    ]. A bruit was heard in 50 percent of cases, fever was observed in 48 percent, and there was bleeding at the injection site in 15 percent of cases. In some cases, infected aneurysm may be masked by overlying inflammation. Thus, the presence of a soft tissue infection in association with a major blood vessel should raise suspicion for an infected aneurysm. Infected aneurysm can be easily misdiagnosed as cellulitis, abscess, or thrombophlebitis.",
"   </p>",
"   <p>",
"    For deeper sites, the aneurysm may not be palpable and may be apparent only on imaging studies. Infected aneurysms involving the aorta or iliac arteries may be accompanied by abdominal or back pain. On the other hand, patients with infected aortic aneurysm may manifest only with fever of unknown origin, some of whom will remain undiagnosed until rupture. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/16/32010?source=see_link\">",
"     \"Clinical features and diagnosis of abdominal aortic aneurysm\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Infected aortic aneurysm must be distinguished from inflammatory aortic aneurysm, which can have similar clinical features, such as fever, weight loss, nonspecific abdominal pain, and elevated erythrocyte sedimentation rate (ESR) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/92\">",
"     92",
"    </a>",
"    ]. Inflammatory aneurysms are characterized by an inflammatory infiltrate in the aortic adventitia associated with adventitial fibrosis. Diagnostic signs on abdominal computed tomography (CT) help to differentiate these. (See",
"    <a class=\"local\" href=\"#H3895948\">",
"     'Infected versus inflammatory aneurysm'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Infected aneurysm of the intracerebral vessels may present as stroke or subarachnoid hemorrhage, particularly in the setting of endocarditis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1118580\">",
"    <span class=\"h2\">",
"     Other manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Undiagnosed, infected aneurysms lead to progressive infection, sepsis, thrombosis or hemorrhage, the manifestations of which depend on location. Some of these include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gastrointestinal bleeding. Although gastrointestinal bleeding is more commonly caused by an infected aortic graft, a primary aorto-duodenal fistula may be due to an infected aortic aneurysm by erosion of the vessel into the third part of the duodenum [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/49,93,94\">",
"       49,93,94",
"      </a>",
"      ]. Rupture of an infected aneurysm into other gastrointestinal structures, such as the appendix [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/95\">",
"       95",
"      </a>",
"      ] or esophagus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/96\">",
"       96",
"      </a>",
"      ], can also occur.",
"     </li>",
"     <li>",
"      Heart failure. As with noninfected aneurysms, rupture of an infected aneurysm into a vein results in arteriovenous fistula [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/97\">",
"       97",
"      </a>",
"      ]. If a large enough artery and vein are involved, high output heart failure may result. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/47/9978?source=see_link\">",
"       \"High-output heart failure\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acutely expanding hematoma. For infected aneurysms that are superficial, the hematoma will be easily seen. Retroperitoneal hematoma from infected aortic or iliac aneurysm rupture may lead to hypovolemic shock. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/61/11225?source=see_link&amp;anchor=H53322839#H53322839\">",
"       \"Management of symptomatic (non-ruptured) and ruptured abdominal aortic aneurysm\", section on 'Introduction'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acute or chronic mesenteric ischemia. Infected aneurysm of the superior mesenteric artery may acutely thrombose or embolize into the terminal mesenteric branches leading to symptoms of intestinal ischemia. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/21/44377?source=see_link\">",
"       \"Acute mesenteric ischemia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/27/33206?source=see_link\">",
"       \"Chronic mesenteric ischemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Peripheral ischemia. Infected aneurysm of the peripheral arteries may acutely thrombose or embolize distally. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/3/13368?source=see_link\">",
"       \"Acute arterial occlusion of the lower extremities (acute limb ischemia)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/58/19370?source=see_link\">",
"       \"Treatment of chronic lower extremity critical limb ischemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Dysphagia and hoarseness. Enlarging or ruptured carotid or subclavian artery aneurysm may compress the structures of the neck leading to stenosis or deviation of the trachea [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/98\">",
"       98",
"      </a>",
"      ] or impingement of the laryngeal nerves similar to that seen as a complication of carotid surgery.",
"     </li>",
"     <li>",
"      Hemoptysis. A mass due to a pulmonary artery aneurysm may be seen during bronchoscopy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/99\">",
"       99",
"      </a>",
"      ]. Rupture of pulmonary artery aneurysm may lead to massive hemoptysis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/100\">",
"       100",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30454?source=see_link\">",
"       \"Massive hemoptysis: Initial management\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Osteomyelitis. Infection of the aorta may extend to thoracic or lumbar spine [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/101\">",
"       101",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/28/22985?source=see_link&amp;anchor=H6#H6\">",
"       \"Vertebral osteomyelitis and discitis\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Psoas abscess. Extension of infection from an aortic or iliac aneurysm to the psoas muscle may cause flank pain, inguinal pain, and limping [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/74\">",
"       74",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neuropathy. Infected aneurysms can impinge on the nerves supplying the extremities [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/102\">",
"       102",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/44/8906?source=see_link\">",
"       \"Overview of upper extremity peripheral nerve syndromes\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/15/42233?source=see_link\">",
"       \"Overview of lower extremity peripheral nerve syndromes\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Suspicion of an infected aneurysm based upon history and physical findings should be followed up with laboratory and imaging studies. The diagnosis of an infected aneurysm is based upon imaging the aneurysm and infection is confirmed by culturing an organism from the blood. Computed tomography (CT) angiography definitively diagnoses the aneurysm, specific features suggest infection, and CT also simultaneously evaluates the status of the circulation. (See",
"    <a class=\"local\" href=\"#H20047525\">",
"     'Imaging'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    On laboratory examination, an increased white blood cell count is found in 64 to 71 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/46,103,104\">",
"     46,103,104",
"    </a>",
"    ]. Inflammatory markers, including C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), are generally elevated.",
"   </p>",
"   <p>",
"    Blood cultures (aerobic, anaerobic, fungal) should be obtained in any patient with a suspected infected aneurysm. Because blood culture may be negative in 25 to 50 percent of patients, negative blood cultures alone are not sufficient to rule out infected aneurysm.",
"   </p>",
"   <p>",
"    An infected aneurysm may be first suspected in the operating room based upon purulence in association with a pre-existing aneurysm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/105\">",
"     105",
"    </a>",
"    ]. Tissue samples of the aneurysm wall should be sent for culture (aerobic, anaerobic, fungal) and Gram stain. In the operating room, a negative Gram stain is not sufficient to exclude a diagnosis of infected aneurysm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/103\">",
"     103",
"    </a>",
"    ]. Conversely, positive tissue cultures in the absence of clinical findings do not confirm an infected aneurysm in the absence of appropriate clinical findings. In one study, 69 percent of patients had positive preoperative blood cultures and 92 percent had positive aneurysm wall cultures, but the operative Gram stain was positive in only 50 percent of patients with ruptured infected aneurysms and 11 percent of unruptured but infected aneurysms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/103\">",
"     103",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20047525\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of imaging studies have been used to identify infected aneurysm, including ultrasound, CT, magnetic resonance (MR) imaging and digital subtraction angiography (DSA). Of these, CT angiography is the most useful for diagnosing infected aneurysm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/106\">",
"     106",
"    </a>",
"    ]. MR angiography is an alternative diagnostic study when intravenous contrast is contraindicated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/107\">",
"     107",
"    </a>",
"    ]. When vascular imaging is consistent with an infected aneurysm, we prefer to perform additional imaging of the remainder of the vasculature to identify multifocal disease.",
"   </p>",
"   <p>",
"    Findings on CT angiography suggestive of an infected aneurysm include the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/106,108-112\">",
"     106,108-112",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Saccular, eccentric aneurysm or multilobulated aneurysm",
"     </li>",
"     <li>",
"      Soft tissue inflammation or mass around a vessel",
"     </li>",
"     <li>",
"      Aneurysm with intramural air or air collection around the vessel",
"     </li>",
"     <li>",
"      Perivascular fluid collection",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the mesenteric circulation, indistinct fat planes may be indicative of vascular inflammation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/113,114\">",
"     113,114",
"    </a>",
"    ]. If a diagnosis of infected aneurysm remains in doubt, a repeat scan can be performed after a short interval to evaluate for rapid enlargement or changes to the aneurysm that suggest infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/109-111\">",
"     109-111",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ultrasound is useful for diagnosing the presence of an aneurysm; however, findings on ultrasound are not reliable for delineating the presence or extent of infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/16/10506?source=see_link&amp;anchor=H58544718#H58544718\">",
"     \"Noninvasive diagnosis of arterial disease\", section on 'Ultrasound'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    DSA is not reliable for identifying infected aneurysm; DSA is also invasive and associated with potential hazards. Nuclear medicine studies, including",
"    <span class=\"nowrap\">",
"     FDG/PET",
"    </span>",
"    and gallium scanning, are alternative modalities for evaluating infected aneurysm, although these are less commonly used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/115-121\">",
"     115-121",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/16/32010?source=see_link\">",
"     \"Clinical features and diagnosis of abdominal aortic aneurysm\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3895948\">",
"    <span class=\"h3\">",
"     Infected versus inflammatory aneurysm",
"    </span>",
"    &nbsp;&mdash;&nbsp;An inflammatory aneurysm is defined as an aneurysm with a &ge;1 cm thickness inflammatory rind surrounding the aorta on CT. The periaortic soft tissue density sometimes enhances with intravenous contrast and the ureters may be deviated medially [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/92\">",
"     92",
"    </a>",
"    ]. Periaortic fibrosis associated with inflammatory aneurysm may result in adhesion of adjacent structures, such as the ureters and duodenum to aorta, leading to indistinct retroperitoneal tissue planes on imaging studies. Inflammatory aneurysms are",
"    <strong>",
"     not",
"    </strong>",
"    associated with periaortic air or fluid and are not infected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no randomized trials to guide the management of infected aneurysms. Management strategies are primarily based upon clinical experience guided by case series. The standard treatment of most infected aneurysms is antibiotic therapy combined with surgical debridement with or without revascularization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/103\">",
"     103",
"    </a>",
"    ]. Revascularization procedures are performed, as needed, depending upon the affected vascular bed and status of distal perfusion. For patients who refuse surgery or who have significant medical comorbidities that preclude surgical intervention, antibiotic therapy alone is an option. Endovascular techniques are emerging as a treatment alternative for infected aneurysm, most commonly for infected aortic aneurysms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/122-132\">",
"     122-132",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20046089\">",
"     'Role of endovascular techniques'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1118621\">",
"    <span class=\"h2\">",
"     Antibiotic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial choice of antibiotic therapy should be guided by the most likely infecting organism based upon the clinical circumstances. Prior to the availability of culture results, we favor treatment with a combination of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    and an agent with activity against gram-negative organisms, especially Salmonella and enteric gram-negatives; reasonable choices include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    , a fluoroquinolone, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/41/24216?source=see_link\">",
"     piperacillin-tazobactam",
"    </a>",
"    . Antibiotics should be tailored to culture and susceptibility results, when they become available.",
"   </p>",
"   <p>",
"    The optimal duration of antibiotic therapy is uncertain and depends on factors, including the immune competence of patient, location of infection, specific bacteria, autogenous versus prosthetic grafts, in-situ versus extra-anatomic reconstruction, and response to treatment (fever, white count, hemodynamic stability). In general, at least six weeks of parenteral",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    oral antimicrobial therapy is administered for treatment of infected aneurysm. If surgical drainage is performed, this time period commences from the day of surgery. However, there are no data to support a specific duration of antibiotic therapy; in some circumstances, particularly for cases in which autologous vein grafting is used, a shorter duration may be sufficient. A longer duration of treatment may be warranted in the setting of antibiotic-resistant organisms, persistently positive cultures",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inflammatory markers that are slow to normalize [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/133\">",
"     133",
"    </a>",
"    ]. Suppressive oral antibiotics following completion of intravenous therapy may be warranted for patients reconstructed with prosthetic graft material in-situ during active infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/8,134,135\">",
"     8,134,135",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management of infected aneurysms follows the general principles of managing vascular graft infection. The main surgical aim is removal of all necrotic and infected tissue and management of any ensuing ischemia. The decision to pursue vascular reconstruction depends primarily upon the patient&rsquo;s underlying vascular status and the anatomic site of the aneurysm (which determines the likelihood of ischemia distal to the site following aneurysm excision), but also on the availability of autologous graft material [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/134,136-142\">",
"     134,136-142",
"    </a>",
"    ]. In many cases, the approach may need to be changed during the course of surgical exploration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8508712\">",
"    <span class=\"h3\">",
"     Aneurysm excision and ligation without arterial reconstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following proximal and distal control of the involved artery, the infected aneurysm and surrounding infected tissue are excised. The major inflow and outflow vessels to the aneurysm should be dissected back to normal tissue. These vessels are oversewn with permanent suture and ligated 1 to 2 cm more proximally to prevent blowout of the arterial stump. Smaller branches can be suture-ligated. Antegrade instillation of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    into the ligated artery may help preserve arterial collaterals, but ongoing anticoagulation therapy is generally not needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8508726\">",
"    <span class=\"h3\">",
"     Excision with immediate reconstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some form of immediate arterial reconstruction will be required in patients who are likely to develop acute ischemia with arterial ligation. The disadvantage of immediate reconstruction is the potential for recurrent infection or hemorrhage due to breakdown of the anastomoses. The decision to perform in-situ repair or extra-anatomic bypass depends upon a variety of factors, including the anatomic site, and presence and severity of peripheral artery disease, but the nature and virulence of the infection also play a role. Many successful in-situ reconstructions using autogenous vein and antibiotic impregnated grafts have been performed for primary arterial infections, including those due to Salmonella [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/134,143\">",
"     134,143",
"    </a>",
"    ], and Staphylococcus epidermidis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/144\">",
"     144",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8476375\">",
"     'Thoracic aorta'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H8510679\">",
"     'Abdominal aorta and iliac arteries'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In some cases, it may be preferable to perform an extra-anatomic bypass prior to excision of the aneurysm to minimize the duration of ischemia. In-situ reconstruction may be necessary for some anatomic sites (eg, thoracic aorta, suprarenal abdominal aorta). On the other hand, a limited infection that is effectively cleared following debridement may be a candidate for in-line autogenous vein reconstruction, but this practice is debated. The selection of patients, timing and methods of reconstruction, particularly when the infected aneurysm involves the aorta or the carotid or femoral artery, remains controversial. (See",
"    <a class=\"local\" href=\"#H1118677\">",
"     'Specific anatomic sites'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    When autogenous superficial vein (eg, great saphenous vein, small saphenous vein, or arm vein) is not available or is inadequate (diameter, length, quality), options include femoral-popliteal deep vein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/145,146\">",
"     145,146",
"    </a>",
"    ], cryopreserved homograft [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/147-151\">",
"     147-151",
"    </a>",
"    ], and prosthetic grafts with or without antibiotic impregnation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/138,152\">",
"     138,152",
"    </a>",
"    ]. The vascular anastomotic sites and conduit should be covered by healthy tissue, which may require rotation of a local muscle flap (eg, sartorius flap, rectus, or gracilis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/153\">",
"     153",
"    </a>",
"    ]. The use of prosthetic grafts is associated with higher rates of reinfection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8508733\">",
"    <span class=\"h3\">",
"     Excision with interval reconstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;When possible, an alternative strategy involves aneurysm excision and debridement with an interval of treatment with antibiotics prior to vascular reconstruction. This option should be considered for patients who are expected to develop only mild to moderate limb ischemia. Unfortunately, it is sometimes difficult to predict intraoperatively whether or not ischemia will become progressive.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20046089\">",
"    <span class=\"h2\">",
"     Role of endovascular techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endovascular therapy may be most suitable for the management of infected aneurysm in high risk patients for whom mortality rates for open surgery would be prohibitive. Endovascular management may also be beneficial for patients with aneurysm rupture, as a temporizing measure, until definitive debridement and reconstruction can be performed under more &lsquo;elective&rsquo; circumstances [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/154-159\">",
"     154-159",
"    </a>",
"    ]. Lastly, endovascular embolization techniques may be appropriate in managing some infected pseudoaneurysms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/160,161\">",
"     160,161",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thoracic endovascular graft repair of infected aneurysm has been reported in case reports and small case series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/122-124,162-167\">",
"     122-124,162-167",
"    </a>",
"    ]. The largest of these series involved thoracic endovascular infected aneurysm repair in 20 patients with etiologies that included one fusiform aneurysm and 18 pseudoaneurysms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/163\">",
"     163",
"    </a>",
"    ]. Three patients died perioperatively. Three additional deaths were attributed to recurrent infection which appeared to be related to infection of the endograft. Overall mortality was 65 percent with a mean survival of 39 &plusmn; 9 months with many deaths related to underlying comorbidities. For patients who have significant comorbidities, thoracic endovascular repair may be an appropriate palliative option given the even higher mortality associated with open surgery in a subset of patients.",
"   </p>",
"   <p>",
"    A systematic review evaluated endovascular management of 91 infected aortic aneurysms (thoracic and abdominal aorta) finding a 90 percent 30-day survival rate and an 82 percent two-year survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/123\">",
"     123",
"    </a>",
"    ]. Logistic regression identified aneurysm rupture and fever as independently associated with persistent infection and mortality. Even when long-term antibiotic therapy has been provided, persistent or recurrent infections occur. Re-operation is associated with high rates of morbidity and mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/123,128,168,169\">",
"     123,128,168,169",
"    </a>",
"    ]. Given that debridement of the infected tissues is not accomplished, the reinfection and late failure rates are not surprising.",
"   </p>",
"   <p>",
"    A later retrospective review identified 19 infected thoracic or abdominal aortic aneurysms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/170\">",
"     170",
"    </a>",
"    ]. Fifteen of these patients had positive blood cultures (79 percent). All 19 patients underwent endovascular repair. The 30-day mortality was 11 percent, and survival at a median of 20 months follow up was 73 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1118677\">",
"    <span class=\"h1\">",
"     SPECIFIC ANATOMIC SITES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8476368\">",
"    <span class=\"h2\">",
"     Intracranial",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cerebral mycotic aneurysms tend to occur in the more distal portions of the middle cerebral artery involving the secondary and tertiary branches near the brain surface. This characteristic pattern helps to distinguish them clinically from berry aneurysms, which tend to occur near the base of the brain and the circle of Willis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/171\">",
"     171",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/40/25225?source=see_link\">",
"     \"Unruptured intracranial aneurysms\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A review of intracranial infected aneurysms complicating endocarditis found that the most important factor when considering treatment of cerebral aneurysms is whether the aneurysm has ruptured [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/172\">",
"     172",
"    </a>",
"    ]. Treatment-related mortality was higher in patients with ruptured aneurysms than in patients with unruptured aneurysms (24 versus 9 percent, respectively). Among patients with ruptured aneurysms, mortality was higher in those treated with antibiotics alone compared with those treated with both antibiotics and surgery (49 versus 12 percent).",
"   </p>",
"   <p>",
"    For these reasons, unruptured aneurysms may be managed with antibiotics alone, but whenever possible, ruptured aneurysms should be managed with a combination of antibiotics and surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/173\">",
"     173",
"    </a>",
"    ]. Several studies report obliterating infected cerebral aneurysms using endovascular techniques [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/174-176\">",
"     174-176",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8476375\">",
"    <span class=\"h2\">",
"     Thoracic aorta",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infected aneurysm of the thoracic aorta is rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/177\">",
"     177",
"    </a>",
"    ]. Most reported series have fewer than 50 patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/178-183\">",
"     178-183",
"    </a>",
"    ]. In one of the larger case series involving 32 primary infected aneurysms, the morphology was primarily pseudoaneurysm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/180\">",
"     180",
"    </a>",
"    ]. The distribution between the aortic arch and descending aorta was equal.",
"   </p>",
"   <p>",
"    Thoracic endovascular aortic repair is becoming the preferred treatment (provided there is no aero-digestive communication) for patients with infected thoracic aortic pseudoaneurysm, given the high morbidity and mortality associated with open surgical repair in these patients, who tend to be older and have significant cardiovascular risk factors.",
"   </p>",
"   <p>",
"    Debridement and in-situ reconstruction of the thoracic aorta remains the preferred approach for thoracic aortic graft infection. Following debridement, surgical reconstruction techniques are similar to those used to repair noninfected aneurysm. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/7/10361?source=see_link\">",
"     \"Management and outcome of thoracic aortic aneurysm\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the above-mentioned series, clinical symptoms consisted of fever, chest pain, hemoptysis, respiratory failure, hoarseness, loss of consciousness, and stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/180\">",
"     180",
"    </a>",
"    ]. The most common microorganisms were nontyphoid Salmonella (57 percent) and S. aureus (14 percent). Among patients who underwent surgery (debridement and in-situ reconstruction), morbidity and one-year mortality rates were the highest for patients with infected arch aneurysms (70 and 50 percent, respectively) compared with infected proximal descending (33 and 16 percent, respectively) or distal descending aneurysms (56 and 33 percent, respectively). Mortality among patients who were managed without surgery (antibiotics only) was 85 percent, with two-thirds of these due to in-hospital rupture. In another series that included aortic aneurysm, no patient who had a ruptured infected aneurysm survived [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/184\">",
"     184",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8510679\">",
"    <span class=\"h2\">",
"     Abdominal aorta and iliac arteries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mortality related to infected aortic aneurysm is lower when medical and surgical therapies are combined (38 versus 96 percent) compared with medical treatment alone. Following debridement of an infected infrarenal aortic aneurysm, extra-anatomic reconstruction (eg, axillofemoral bypass) is generally preferred [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/136,185-187\">",
"     136,185-187",
"    </a>",
"    ]. Placement of prosthetic graft material into the infected retroperitoneum is associated with a 25 percent reoperation rate that increases to 63 percent when the infecting organism is a gram-negative organism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/137,188\">",
"     137,188",
"    </a>",
"    ]. As an alternative, autogenous vein can be used. The incidence of reinfection is low when neoaortic iliac system (NAIS) reconstruction is used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/189\">",
"     189",
"    </a>",
"    ]. On the other hand, a disadvantage of axillobifemoral bypass is the greater potential for graft thrombosis compared with aortofemoral reconstruction.",
"   </p>",
"   <p>",
"    For infected suprarenal aneurysm, in-situ repair is generally performed to preserve visceral flow, though in some cases, in-situ reconstruction is not possible and extra-anatomic bypass is necessary [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/129,142,190-192\">",
"     129,142,190-192",
"    </a>",
"    ]. In one study of 28 patients with primary infection of the aorta, no significant difference in mortality was found for patients undergoing in-situ reconstruction compared with extra-anatomic bypass [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/143\">",
"     143",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For infected aortic aneurysms, perioperative mortality is 15 to 20 percent. The morbidity and mortality of infected aneurysm is related to inability to clear the infection and development of end-organ ischemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/14,46,103,104\">",
"     14,46,103,104",
"    </a>",
"    ]. Survival is better for infrarenal abdominal aortic aneurysms (96 versus 57 percent) compared with noninfrarenal aneurysms. Late complications are common occurring in 30 to 70 percent of patients and are frequently a cause of death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/143,180\">",
"     143,180",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8476382\">",
"    <span class=\"h2\">",
"     Extracranial carotid artery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The innominate artery and common carotid artery may tolerate ligation without reconstruction; however, ligation of the internal carotid artery is associated with a 30 to 40 percent incidence of stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/193-195\">",
"     193-195",
"    </a>",
"    ]. Most surgeons favor immediate reconstruction with autogenous vein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/196\">",
"     196",
"    </a>",
"    ]. An alternative technique involves a test occlusion of the internal carotid artery while monitoring for signs of cerebral ischemia as is done in carotid endarterectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/197\">",
"     197",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/27/40378?source=see_link&amp;anchor=H93838556#H93838556\">",
"     \"Carotid endarterectomy\", section on 'Assessing brain perfusion'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8476403\">",
"    <span class=\"h2\">",
"     Lower extremity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infected aneurysms of the lower extremity arteries most commonly involve the vessels in the groin. The popliteal artery may also be affected but infected aneurysm of the vessels below the knee is rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/198\">",
"     198",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, ligation of the arteries in the groin may be tolerated if ligation is limited to a single vessel (common femoral artery, superficial femoral artery or deep femoral artery), and provided that collateral flow is adequate (",
"    <a class=\"graphic graphic_figure graphicRef72956 \" href=\"mobipreview.htm?25/60/26566\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/199,200\">",
"     199,200",
"    </a>",
"    ]. Lower extremity ischemia is more likely if the femoral bifurcation needs to be excised completely.",
"   </p>",
"   <p>",
"    Options for surgical revascularization of the lower extremity include interposition graft (autogenous graft) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/201,202\">",
"     201,202",
"    </a>",
"    ], obturator bypass (autogenous or prosthetic graft), lateral femoral bypass (autogenous or prosthetic graft), and axillary to distal femoral bypass (prosthetic graft).",
"   </p>",
"   <p>",
"    Although prosthetic graft material may be needed for extra-anatomic reconstruction, it should be avoided in the patient with a history of active intravenous drug use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/138,203-210\">",
"     138,203-210",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As with infected aortic aneurysms, exclusion of infected popliteal aneurysm has been managed with endovascular stenting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/211,212\">",
"     211,212",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20046089\">",
"     'Role of endovascular techniques'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Amputation following management of infected femoral artery pseudoaneurysm is required in 11 to 25 percent of patients. The amputation rate in patients with intravenous drug abuse is higher at approximately 30 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8476389\">",
"    <span class=\"h2\">",
"     Visceral arteries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mycotic aneurysms of the visceral vessels most commonly involve the superior mesenteric artery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/213\">",
"     213",
"    </a>",
"    ]. Infected aneurysms of the splenic and renal artery have also been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/159,214\">",
"     159,214",
"    </a>",
"    ]. Aneurysm ligation and excision is the preferred treatment provided intestinal ischemia does not develop [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/113,215\">",
"     113,215",
"    </a>",
"    ]. The management of acute and chronic intestinal ischemia is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/21/44377?source=see_link\">",
"     \"Acute mesenteric ischemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/27/33206?source=see_link\">",
"     \"Chronic mesenteric ischemia\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8476396\">",
"    <span class=\"h2\">",
"     Upper extremity",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the upper extremity, the brachial artery is the most commonly affected site primarily due to intravenous drug abuse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/216\">",
"     216",
"    </a>",
"    ]. These superficial aneurysms are usually readily apparent clinically. Subclavian aneurysms can compress the surrounding neurovascular structures leading to symptoms of venous thrombosis or brachial plexopathy, which are discussed in individual topic reviews [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/17/35098/abstract/102\">",
"     102",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Upper extremity vessels, including the subclavian and brachial vessels, often tolerate ligation without ischemic consequences owing to the low metabolic rate of the upper extremity musculature and collateral circulation around the shoulder (",
"    <a class=\"graphic graphic_figure graphicRef66933 \" href=\"mobipreview.htm?18/1/18454\">",
"     figure 2",
"    </a>",
"    ) and elbow.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13204212\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An infected aneurysm is a localized dilation of an artery due to destruction of the vessel wall by infection. An infected aneurysm can develop when infection of the arterial wall causes development of a new aneurysm, or when a pre-existing aneurysm becomes secondarily infected. (See",
"      <a class=\"local\" href=\"#H20047087\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The organisms with the greatest affinity for the arterial wall and more likely to cause infected aneurysm are Staphylococcus spp and Salmonella spp. Other organisms include Streptococcus pneumoniae, Treponema pallidum and Mycobacterium tuberculosis, as well as other bacterial, fungal, or anaerobic pathogens. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infected aneurysms can occur in any artery but are most commonly seen in the extremity, splanchnic, and cerebral circulations often at points of vessel bifurcation. Risk factors for infected aneurysm include trauma, endocarditis, impaired immunity, and advanced age. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical manifestations depend upon the site of the aneurysm. The classic presentation is a painful, pulsatile, and enlarging mass together with systemic features of infection, such as fever and malaise. The mass may be palpable or demonstrable only by imaging. In the setting of aneurysm involving the aorta, the patients may complain of back or abdominal pain may. Infected aneurysms can rupture presenting as expanding hematoma or if an intracerebral vessel is affected, as stroke or subarachnoid hemorrhage. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of an infected aneurysm is based upon imaging the aneurysm and infection is confirmed by culturing an organism from the blood. Computed tomography (CT) angiography definitively diagnoses the aneurysm and simultaneously evaluates the status of the circulation. Findings on CT angiography suggestive of infected aneurysm include the following. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Saccular, eccentric aneurysm or multilobulated aneurysm.",
"     </li>",
"     <li>",
"      Soft tissue inflammation or mass around a vessel.",
"     </li>",
"     <li>",
"      Aneurysm with intramural air or air collection around the vessel.",
"     </li>",
"     <li>",
"      Perivascular fluid collection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prior to the availability of culture results, we favor treatment with a combination of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      and an agent with activity against gram-negative organisms, especially Salmonella and enteric gram-negatives; reasonable choices include",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/17/10521?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      , a fluoroquinolone, and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/41/24216?source=see_link\">",
"       piperacillin-tazobactam",
"      </a>",
"      . Antibiotics should be tailored to culture and susceptibility results, when they become available. The duration of therapy is individualized. (See",
"      <a class=\"local\" href=\"#H1118621\">",
"       'Antibiotic therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      At extracranial sites in patients with an acceptable surgical risk, surgical excision of the aneurysm and wide debridement of infected tissues is the treatment of choice. Revascularization is performed, as needed, preferably using autogenous material passed through tissue planes remote from the site of infection. Patients with a high surgical risk and at some anatomic sites (eg, nonruptured intracerebral) may be best managed with antibiotic therapy alone. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Management'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For nonruptured infected true aneurysms in patients who are not at high risk for surgery, we prefer open surgical over endovascular methods as the primary mode of treatment. Endovascular stenting does not remove the infected focus of infection, and recurrent infection is frequent and associated with increased morbidity and mortality compared with primary surgical intervention. Endovascular techniques may be useful as a palliative measure for patients who refuse surgery, those with a prohibitive risk for surgery, and possibly for patients with ruptured infected aneurysm, as a means to contain the rupture, thus allowing definitive treatment under more elective circumstances. (See",
"      <a class=\"local\" href=\"#H20046089\">",
"       'Role of endovascular techniques'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/1\">",
"      Osler W. The Gulstonian Lectures, on Malignant Endocarditis. Br Med J 1885; 1:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/2\">",
"      Bisdas T, Teebken OE. Mycotic or infected aneurysm? Time to change the term. Eur J Vasc Endovasc Surg 2011; 41:570; author reply 570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/3\">",
"      Qureshi T, Hawrych AB, Hopkins NF. Mycotic aneurysm after percutaneous transluminal femoral artery angioplasty. J R Soc Med 1999; 92:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/4\">",
"      Samore MH, Wessolossky MA, Lewis SM, et al. Frequency, risk factors, and outcome for bacteremia after percutaneous transluminal coronary angioplasty. Am J Cardiol 1997; 79:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/5\">",
"      Chan YC, Ting AC, Law S, Cheng SW. Secondary infection of a pre-existing thoracic aortic aneurysm by iatrogenic oesophageal perforation with aorta-oesophageal fistula formation. Eur J Cardiothorac Surg 2009; 35:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/6\">",
"      Kunishige H, Myojin K, Ishibashi Y, et al. Perforation of the esophagus by a fish bone leading to an infected pseudoaneurysm of the thoracic aorta. Gen Thorac Cardiovasc Surg 2008; 56:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/7\">",
"      Gleeton D, Levesque S, Tr&eacute;panier CA, et al. Symptomatic axillary hematoma after ultrasound-guided infraclavicular block in a patient with undiagnosed upper extremity mycotic aneurysms. Anesth Analg 2010; 111:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/8\">",
"      Brown SL, Busuttil RW, Baker JD, et al. Bacteriologic and surgical determinants of survival in patients with mycotic aneurysms. J Vasc Surg 1984; 1:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/9\">",
"      Johansen K, Devin J. Mycotic aortic aneurysms. A reappraisal. Arch Surg 1983; 118:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/10\">",
"      Serracino-Inglott F, Snow D, Madan M. A rapidly expanding mycotic abdominal aortic aneurysm. J Am Coll Surg 2005; 200:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/11\">",
"      Paraskevas KI, Mikhailidis DP, Giannoukas AD. Periodontitis and abdominal aortic aneurysms: a random association or a pathogenetic link? Int Angiol 2009; 28:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/12\">",
"      Wada K, Kamisaki Y. Roles of oral bacteria in cardiovascular diseases--from molecular mechanisms to clinical cases: Involvement of Porphyromonas gingivalis in the development of human aortic aneurysm. J Pharmacol Sci 2010; 113:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/13\">",
"      Dieter RA. Dental mycotic abdominal aneurysm. J Am Coll Surg 2005; 201:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/14\">",
"      Oderich GS, Panneton JM, Bower TC, et al. Infected aortic aneurysms: aggressive presentation, complicated early outcome, but durable results. J Vasc Surg 2001; 34:900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/15\">",
"      Kaneko K, Nonomura Y, Watanabe K, et al. Infected abdominal aortic aneurysm caused by nontyphoid Salmonella in an immunocompromised patient with rheumatoid arthritis. J Infect Chemother 2009; 15:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/16\">",
"      Hajir N, Macaulay E. Occult caecal malignancy leading to mycotic abdominal aortic aneurysm rupture. ANZ J Surg 2010; 80:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/17\">",
"      Bowden DJ, Hayes PD, Sadat U, Choon See T. Mycotic pseudoaneurysm of the superficial femoral artery in a patient with Cushing disease: case report and literature review. Vascular 2009; 17:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/18\">",
"      Sever M, Verstovsek S, Erasmus J Jr, Mattiuzzi GN. Mycotic pulmonary artery aneurysm due to Aspergillus infection in a patient with leukemia: case report and review of the literature. Leuk Res 2010; 34:e133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/19\">",
"      Har-Shai Y, Schein M, Molek AD, et al. Ruptured mycotic aneurysm of the subclavian artery after irradiation. A case report. Eur J Surg 1993; 159:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/20\">",
"      Yoneda K, Shiraki K, Tanaka J, et al. Cervical mycotic aneurysm in a patient with alcoholic cirrhosis. Intern Med 2007; 46:1693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/21\">",
"      Mercadal L, Chiche L, Isnard-Bagnis C, et al. Mycotic aneurysm in hemodialysis. Clin Nephrol 2005; 64:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/22\">",
"      Sailors DM, Barone GW, Gagn&eacute; PJ, et al. Candida arteritis: are GI endoscopic procedures a source of vascular infections? Am Surg 1996; 62:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/23\">",
"      Sharma K, Kibria R, Ali S, Rao P. Primary aortoenteric fistula caused by an infected abdominal aortic aneurysm with Mycobacterium avium complex in an HIV patient. Acta Gastroenterol Belg 2010; 73:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/24\">",
"      Modi G, Ranchod K, Modi M, Mochan A. Human immunodeficiency virus associated intracranial aneurysms: report of three adult patients with an overview of the literature. J Neurol Neurosurg Psychiatry 2008; 79:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/25\">",
"      Ortmann C, W&uuml;llenweber J, Brinkmann B, Fracasso T. Fatal mycotic aneurysm caused by Pseudallescheria boydii after near drowning. Int J Legal Med 2010; 124:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/26\">",
"      Macbeth GA, Rubin JR, McIntyre KE Jr, et al. The relevance of arterial wall microbiology to the treatment of prosthetic graft infections: graft infection vs. arterial infection. J Vasc Surg 1984; 1:750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/27\">",
"      Sedivy P, Sebesta P, Trejbalov&aacute; E, Henysov&aacute; J. Infected false aneurysm caused by hematogenous dissemination of Staphylococcus aureus after the use of vaginal tampons. Int Angiol 2008; 27:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/28\">",
"      Ernst CB, Campbell HC Jr, Daugherty ME, et al. Incidence and significance of intra-operative bacterial cultures during abdominal aortic aneurysmectomy. Ann Surg 1977; 185:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/29\">",
"      Garb M. Appendicitis: an unusual cause of infected abdominal aortic aneurysm. Australas Radiol 1994; 38:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/30\">",
"      Fraser CD 3rd, Arnaoutakis GJ, George TJ, et al. Acute cholecystitis preceding mycotic aortic pseudoaneurysm in a heart transplant recipient. J Card Surg 2010; 25:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/31\">",
"      Mazzalai F, Ragazzi R, Iurilli V, et al. Pseudomonas aeruginosa-infected infrarenal abdominal aorta pseudoaneurysm secondary to laparoscopic colorectal surgery: failure of endovascular stent graft treatment after primary open repair failed. Can J Surg 2009; 52:E193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/32\">",
"      Nunoo-Mensah JW, Ritter MP, Wasserberg N, et al. Pseudoaneurysm of the inferior gluteal artery: an unusual complication after abdominoperineal resection for rectal cancer. Report of a case. Dis Colon Rectum 2007; 50:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/33\">",
"      Maalouf M, Moon W, Leers S, et al. Mycotic aneurysm of the infrarenal aorta after drainage of an infected chronic pancreatic pseudocyst: case report and review of the literature. Am Surg 2007; 73:1266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/34\">",
"      Behnke NM, Cui Q, Orndorff D. Late presentation of a mycotic popliteal artery pseudoaneurysm in the setting of a revised total knee arthroplasty complicated by both prior infection and periprosthetic fracture: a case report. Ann Vasc Surg 2007; 21:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/35\">",
"      Smith GH, Nutton RW, Fraser SC. Iliac artery pseudoaneurysm rupture following excision of an infected hip prosthesis. J Arthroplasty 2011; 26:977.e13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/36\">",
"      Sawbridge D, O'Connor OJ, MacEneaney P, et al. Successful endovascular treatment of an infected external iliac pseudoaneurysm with hemorrhage at total hip arthroplasty. J Vasc Interv Radiol 2010; 21:1135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/37\">",
"      Woo SB, Cheng LC, Wong WC. Mycotic aortic aneurysm following treatment of pyogenic vertebral osteomyelitis. Asian Cardiovasc Thorac Ann 2006; 14:e102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/38\">",
"      Learch TJ, Sakamoto B, Ling AC, Donovan SM. Salmonella spondylodiscitis associated with a mycotic abdominal aortic aneurysm and paravertebral abscess. Emerg Radiol 2009; 16:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/39\">",
"      Chen SH, Lin WC, Lee CH, Chou WY. Spontaneous infective spondylitis and mycotic aneurysm: incidence, risk factors, outcome and management experience. Eur Spine J 2008; 17:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/40\">",
"      Wu FZ, Lai PH. Evolution and regression of intracranial infectious aneurysm diagnosed by brain computed tomographic angiography. Arch Neurol 2010; 67:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/41\">",
"      Johansen K, Devin J. Spontaneous healing of mycotic aortic aneurysms. J Cardiovasc Surg (Torino) 1980; 21:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/42\">",
"      Bozkurt AK, Oztun&ccedil; F, Akman C, et al. Multiple pulmonary artery aneurysms due to infective endocarditis. Ann Thorac Surg 2003; 75:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/43\">",
"      Negishi K, Ono Y, Kurosawa K, et al. Infective endocarditis complicated by mycotic aneurysm of a coronary artery with a perforated mitral valvular aneurysm. J Am Soc Echocardiogr 2009; 22:542.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/44\">",
"      Johnson JR, Ledgerwood AM, Lucas CE. Mycotic aneurysm. New concepts in therapy. Arch Surg 1983; 118:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/45\">",
"      Maeda H, Umezawa H, Goshima M, et al. Primary infected abdominal aortic aneurysm: surgical procedures, early mortality rates, and a survey of the prevalence of infectious organisms over a 30-year period. Surg Today 2011; 41:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/46\">",
"      Moneta GL, Taylor LM Jr, Yeager RA, et al. Surgical treatment of infected aortic aneurysm. Am J Surg 1998; 175:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/47\">",
"      Brossier J, Lesprit P, Marzelle J, et al. New bacteriological patterns in primary infected aorto-iliac aneurysms: a single-centre experience. Eur J Vasc Endovasc Surg 2010; 40:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/48\">",
"      Marques da Silva R, Caugant DA, Eribe ER, et al. Bacterial diversity in aortic aneurysms determined by 16S ribosomal RNA gene analysis. J Vasc Surg 2006; 44:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/49\">",
"      Lew WK, Rowe VL, Cunningham MJ, Weaver FA. Endovascular management of mycotic aortic aneurysms and associated aortoaerodigestive fistulas. Ann Vasc Surg 2009; 23:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/50\">",
"      Utsumi T, Ohtsuka M, Uchida E, et al. Abdominal aortic pseudoaneurysm caused by prolonged methicillin-resistant Staphylococcus aureus sepsis. Int J Cardiol 2008; 128:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/51\">",
"      Karkos CD, Burnett C, Buckely H, et al. Mycotic common iliac artery aneurysm complicating methicillin-resistant Staphylococcus aureus bacteremia: an unusual cause of ureteric obstruction. Ann Vasc Surg 2005; 19:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/52\">",
"      Kuo CC, Wu V, Tsai CW, et al. Fatal bacteremic mycotic aneurysm complicated by acute renal failure caused by daptomycin-nonsusceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008; 47:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/53\">",
"      Hsu RB, Tsay YG, Wang SS, Chu SH. Surgical treatment for primary infected aneurysm of the descending thoracic aorta, abdominal aorta, and iliac arteries. J Vasc Surg 2002; 36:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/54\">",
"      Brouwer RE, van Bockel JH, van Dissel JT. Streptococcus pneumoniae, an emerging pathogen in mycotic aneurysms? Neth J Med 1998; 52:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/55\">",
"      Cartery C, Astudillo L, Deelchand A, et al. Abdominal infectious aortitis caused by Streptococcus pneumoniae: a case report and literature review. Ann Vasc Surg 2011; 25:266.e9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/56\">",
"      Dick J, Tiwari A, Menon J, Hamilton G. Abdominal aortic aneurysm secondary to infection with Pseudomonas aeruginosa: a rare cause of mycotic aneurysm. Ann Vasc Surg 2010; 24:692.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/57\">",
"      McCann JF, Fareed A, Reddy S, et al. Multi-resistant Escherichia coli and mycotic aneurysm: two case reports. J Med Case Rep 2009; 3:6453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/58\">",
"      Jarrett F, Darling RC, Mundth ED, Austen WG. Experience with infected aneurysms of the abdominal aorta. Arch Surg 1975; 110:1281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/59\">",
"      Cruz RP, Marrone LC, Marrone AC. Chronic syphilitic aortic aneurysm complicated with chronic aortic dissection. Am J Surg 2010; 200:e64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/60\">",
"      Costiniuk CT, Sharapov AA, Rose GW, et al. Mycobacterium bovis abdominal aortic and femoral artery aneurysms following intravesical bacillus Calmette-Gu&eacute;rin therapy for bladder cancer. Cardiovasc Pathol 2010; 19:e29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/61\">",
"      Canaud L, Marzelle J, Bassinet L, et al. Tuberculous aneurysms of the abdominal aorta. J Vasc Surg 2008; 48:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/62\">",
"      Harding GE, Lawlor DK. Ruptured mycotic abdominal aortic aneurysm secondary to Mycobacterium bovis after intravesical treatment with bacillus Calmette-Gu&eacute;rin. J Vasc Surg 2007; 46:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/63\">",
"      Long R, Guzman R, Greenberg H, et al. Tuberculous mycotic aneurysm of the aorta: review of published medical and surgical experience. Chest 1999; 115:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/64\">",
"      Brunner S, Engelmann MG, N&auml;bauer M. Thoracic mycotic pseudoaneurysm from Candida albicans infection. Eur Heart J 2008; 29:1515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/65\">",
"      Deitch JS, Plonk GW, Hagenstad C, et al. Cryptococcal aortitis presenting as a ruptured mycotic abdominal aortic aneurysm. J Vasc Surg 1999; 30:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/66\">",
"      Mettananda KC, De Silva ST, Premawardhena AP. Mycotic aneurysm of the descending aorta due to Aspergillus species. Ceylon Med J 2010; 55:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/67\">",
"      Chandrikakumari K, Giot JB, de Leval L, et al. Report of a case of Streptococcus agalactiae mycotic aneurysm and review of the literature. Int J Surg Pathol 2008; 16:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/68\">",
"      Seder CW, Kramer M, Long G, et al. Clostridium septicum aortitis: Report of two cases and review of the literature. J Vasc Surg 2009; 49:1304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/69\">",
"      Prech M, Grajek S, Cie��li��ski A, Jemielity M. Mycotic aneurysm of the ascending aorta following CABG. Heart 2000; 83:E3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/70\">",
"      Boudewijns M, Magerman K, Verhaegen J, et al. Rothia dentocariosa, endocarditis and mycotic aneurysms: case report and review of the literature. Clin Microbiol Infect 2003; 9:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/71\">",
"      Papavassiliou VG, Xanthopoulos DK, Argitis VP, et al. Infected ruptured popliteal artery aneurysm by Listeria monocytogenes. A case report and review of the literatures. J Cardiovasc Surg (Torino) 2008; 49:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/72\">",
"      Bal A, Sch&ouml;nleben F, Agaimy A, et al. Listeria monocytogenes as a rare cause of mycotic aortic aneurysm. J Vasc Surg 2010; 52:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/73\">",
"      Resch M, Schichtl T, Endemann DH, et al. General aneurysmatosis due to cheese consumption: complications of an endocarditis caused by Lactococcus cremoris. Int J Cardiol 2008; 126:e8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/74\">",
"      Hsu RB, Lin FY. Psoas abscess in patients with an infected aortic aneurysm. J Vasc Surg 2007; 46:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/75\">",
"      Montero A, Corbella X, L&oacute;pez JA, et al. Campylobacter fetus-associated aneurysms: report of a case involving the popliteal artery and review of the literature. Clin Infect Dis 1997; 24:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/76\">",
"      Onoda M, Furutani A, Akiyama N, et al. Infected aneurysms of bilateral deep femoral arteries due to Campylobacter fetus subspecies fetus. Ann Vasc Surg 2008; 22:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/77\">",
"      La Scola B, Musso D, Carta A, et al. Aortoabdominal aneurysm infected by Yersinia enterocolitica serotype O:9. J Infect 1997; 35:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/78\">",
"      Hadou T, Elfarra M, Alauzet C, et al. Abdominal aortic aneurysm infected by Yersinia pseudotuberculosis. J Clin Microbiol 2006; 44:3457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/79\">",
"      Cakalagaoglu C, Keser N, Alhan C. Brucella-mediated prosthetic valve endocarditis with brachial artery mycotic aneurysm. J Heart Valve Dis 1999; 8:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/80\">",
"      Park SJ, Kim MN, Kwon TW. Infected abdominal aortic aneurysm caused by Brucella abortus: a case report. J Vasc Surg 2007; 46:1277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/81\">",
"      Takahashi Y, Tsutsumi Y, Monta O, et al. Mycotic aneurysm of the descending thoracic aorta caused by Haemophilus influenzae. J Card Surg 2010; 25:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/82\">",
"      Antonopoulos C, Karagianni M, Galanakis N, Vagianos C. Mycotic splenic artery aneurysm secondary to Coxiella burnetii endocarditis. Ann Vasc Surg 2010; 24:416.e13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/83\">",
"      Botelho-Nevers E, Fournier PE, Richet H, et al. Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcome. Eur J Clin Microbiol Infect Dis 2007; 26:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/84\">",
"      Bendermacher BL, Peppelenbosch AG, Daemen JW, et al. Q fever (Coxiella burnetii) causing an infected thoracoabdominal aortic aneurysm. J Vasc Surg 2011; 53:1402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/85\">",
"      Sessa C, Vokrri L, Porcu P, et al. Abdominal aortic aneurysm and Coxiella burnetii infection: report of three cases and review of the literature. J Vasc Surg 2005; 42:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/86\">",
"      Pencavel TD, Singh-Ranger G, Crinnion JN. Conservative treatment of an early aortic graft infection due to Acinetobacter baumanii. Ann Vasc Surg 2006; 20:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/87\">",
"      Low JG, Quek AM, Sin YK, Ang BS. Mycotic aneurysm due to Burkholderia pseudomallei infection: case reports and literature review. Clin Infect Dis 2005; 40:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/88\">",
"      Lee SY, Sin YK, Kurup A, et al. Stent-graft for recurrent melioidosis mycotic aortic aneurysm. Asian Cardiovasc Thorac Ann 2006; 14:e38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/89\">",
"      Rao J, Kaushal AS, Hoong CK. Abdominal aortic pseudoaneurysm secondary to melioidosis. Asian J Surg 2009; 32:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/90\">",
"      Anunnatsiri S, Chetchotisakd P, Kularbkaew C. Mycotic aneurysm in Northeast Thailand: the importance of Burkholderia pseudomallei as a causative pathogen. Clin Infect Dis 2008; 47:1436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/91\">",
"      Lee HL, Liu KH, Yang YJ, Kan CD. Bacteroides fragilis aortic arch pseudoaneurysm: case report with review. J Cardiothorac Surg 2008; 3:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/92\">",
"      Pennell RC, Hollier LH, Lie JT, et al. Inflammatory abdominal aortic aneurysms: a thirty-year review. J Vasc Surg 1985; 2:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/93\">",
"      Skourtis G, Papacharalambous G, Gerasimos P, et al. Primary aortoenteric fistula due to septic aortitis. Ann Vasc Surg 2010; 24:825.e7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/94\">",
"      Zhao J. Massive upper gastrointestinal bleeding due to a ruptured superior mesenteric artery aneurysm duodenum fistula. J Vasc Surg 2008; 48:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/95\">",
"      Keripe S, Slavik S, Oshodi T. Primary aortoappendicular fistula arising from an infected, chronic, contained, ruptured abdominal aortic aneurysm. Ann Vasc Surg 2006; 20:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/96\">",
"      Millar A, Rostom A, Rasuli P, Saloojee N. Upper gastrointestinal bleeding secondary to an aberrant right subclavian artery-esophageal fistula: a case report and review of the literature. Can J Gastroenterol 2007; 21:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/97\">",
"      Shiraishi M, Ohki S, Misawa Y. Mycotic superior mesenteric pseudoaneurysm draining into a vein. Interact Cardiovasc Thorac Surg 2011; 12:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/98\">",
"      Masumoto H, Shimamoto M, Yamazaki F, et al. Airway stenosis associated with a mycotic pseudoaneurysm of the common carotid artery. Gen Thorac Cardiovasc Surg 2008; 56:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/99\">",
"      Dransfield MT, Johnson JE. A mycotic pulmonary artery aneurysm presenting as an endobronchial mass. Chest 2003; 124:1610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/100\">",
"      Greillier L, Barlesi F, Fraticelli A, et al. Fatal pulmonary haemorrhage from a mycotic pulmonary artery aneurysm. Int J Tuberc Lung Dis 2005; 9:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/101\">",
"      Yamamoto H, Yamamoto F, Izumoto H, et al. Repetitive contained rupture of an infected abdominal aortic aneurysm with concomitant vertebral erosion. Ann Vasc Surg 2010; 24:824.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/102\">",
"      Veilleux M, Bourgouin P, Morin JF. Brachial plexopathy secondary to mycotic subclavian-axillary artery aneurysm. Muscle Nerve 1996; 19:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/103\">",
"      Reddy DJ, Shepard AD, Evans JR, et al. Management of infected aortoiliac aneurysms. Arch Surg 1991; 126:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/104\">",
"      Soravia-Dunand VA, Loo VG, Salit IE. Aortitis due to Salmonella: report of 10 cases and comprehensive review of the literature. Clin Infect Dis 1999; 29:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/105\">",
"      Hsu RB, Lin FY. Surgical pathology of infected aortic aneurysm and its clinical correlation. Ann Vasc Surg 2007; 21:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/106\">",
"      Vogelzang RL, Sohaey R. Infected aortic aneurysms: CT appearance. J Comput Assist Tomogr 1988; 12:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/107\">",
"      Walsh DW, Ho VB, Haggerty MF. Mycotic aneurysm of the aorta: MRI and MRA features. J Magn Reson Imaging 1997; 7:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/108\">",
"      Ou P, Sidi D, Bonnet D, Brunelle F. Infected pulmonary artery aneurysms: CT imaging findings. Eur J Cardiothorac Surg 2006; 29:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/109\">",
"      Gomes MN, Choyke PL. Infected aortic aneurysms: CT diagnosis. J Cardiovasc Surg (Torino) 1992; 33:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/110\">",
"      Lee MH, Chan P, Chiou HJ, Cheung WK. Diagnostic imaging of Salmonella-related mycotic aneurysm of aorta by CT. Clin Imaging 1996; 20:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/111\">",
"      Rozenblit A, Bennett J, Suggs W. Evolution of the infected abdominal aortic aneurysm: CT observation of early aortitis. Abdom Imaging 1996; 21:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/112\">",
"      Lee WK, Mossop PJ, Little AF, et al. Infected (mycotic) aneurysms: spectrum of imaging appearances and management. Radiographics 2008; 28:1853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/113\">",
"      Chen CL, Chou AS, Chiu CH. Clinical challenges and images in GI. Mycotic aneurysm of the superior mesenteric artery. Gastroenterology 2006; 131:13, 337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/114\">",
"      Serafino G, Vroegindeweij D, Boks S, van der Harst E. Mycotic aneurysm of the celiac trunk: from early CT sign to rupture. Cardiovasc Intervent Radiol 2005; 28:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/115\">",
"      Spacek M, Stadler P, B��lohl&aacute;vek O, Sebesta P. Contribution to FDG-PET/CT diagnostics and post-operative monitoring of patients with mycotic aneurysm of the thoracic aorta. Acta Chir Belg 2010; 110:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/116\">",
"      Davison JM, Montilla-Soler JL, Broussard E, et al. F-18 FDG PET-CT imaging of a mycotic aneurysm. Clin Nucl Med 2005; 30:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/117\">",
"      Hsu CC, Huang YF, Chuang YW. Detection of an infected abdominal aortic aneurysm with three-phase bone scan and gallium-67 scan. Clin Nucl Med 2008; 33:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/118\">",
"      Choi SJ, Lee JS, Cheong MH, et al. F-18 FDG PET/CT in the management of infected abdominal aortic aneurysm due to Salmonella. Clin Nucl Med 2008; 33:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/119\">",
"      Fukuchi K, Ishida Y, Higashi M, et al. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomographic findings. J Vasc Surg 2005; 42:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/120\">",
"      Bonekamp D, Smith JD, Aygun N. Avid FDG uptake in a rapidly enlarging common carotid artery mycotic aneurysm, mimicking lymphadenopathy. Emerg Radiol 2009; 16:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/121\">",
"      Van der Wall H, Palmer A, Thomas M, Chu J. Bone and leukocyte scintigraphy of a complicated case of ruptured mycotic aneurysm of the aorta. A case history. Angiology 1994; 45:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/122\">",
"      Ugurlucan M, Umaroglu S, Tireli E, Alpagut U. Endovascular treatment of mycotic saccular aneurysms of the thoracic aorta. Interact Cardiovasc Thorac Surg 2011; 12:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/123\">",
"      Kan CD, Lee HL, Yang YJ. Outcome after endovascular stent graft treatment for mycotic aortic aneurysm: a systematic review. J Vasc Surg 2007; 46:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/124\">",
"      Bell RE, Taylor PR, Aukett M, et al. Successful endoluminal repair of an infected thoracic pseudoaneurysm caused by methicillin-resistant Staphylococcus aureus. J Endovasc Ther 2003; 10:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/125\">",
"      Kan CD, Lee HL, Luo CY, Yang YJ. The efficacy of aortic stent grafts in the management of mycotic abdominal aortic aneurysm-institute case management with systemic literature comparison. Ann Vasc Surg 2010; 24:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/126\">",
"      Kinney EV, Kaebnick HW, Mitchell RA, Jung MT. Repair of mycotic paravisceral aneurysm with a fenestrated stent-graft. J Endovasc Ther 2000; 7:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/127\">",
"      Kotzampassakis N, Delanaye P, Masy F, Creemers E. Endovascular stent-graft for thoracic aorta aneurysm caused by Salmonella. Eur J Cardiothorac Surg 2004; 26:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/128\">",
"      Forbes TL, Harding GE. Endovascular repair of Salmonella-infected abdominal aortic aneurysms: a word of caution. J Vasc Surg 2006; 44:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/129\">",
"      Iida Y, Obitsu Y, Yokoi Y, et al. Successful treatment of multiple mycotic aortic aneurysms, using a hybrid procedure. J Vasc Surg 2010; 51:1521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/130\">",
"      S&ouml;relius K, Mani K, Bj&ouml;rck M, et al. Endovascular repair of mycotic aortic aneurysms. J Vasc Surg 2009; 50:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/131\">",
"      Labrousse L, Montaudon M, Le Guyader A, et al. Endovascular treatment of a tuberculous infected aneurysm of the descending thoracic aorta: a word of caution. J Vasc Surg 2007; 46:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/132\">",
"      Ting AC, Cheng SW, Ho P, Poon JT. Endovascular stent graft repair for infected thoracic aortic pseudoaneurysms--a durable option? J Vasc Surg 2006; 44:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/133\">",
"      Cin&agrave; CS, Arena GO, Fiture AO, et al. Ruptured mycotic thoracoabdominal aortic aneurysms: a report of three cases and a systematic review. J Vasc Surg 2001; 33:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/134\">",
"      Chan FY, Crawford ES, Coselli JS, et al. In situ prosthetic graft replacement for mycotic aneurysm of the aorta. Ann Thorac Surg 1989; 47:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/135\">",
"      Hsu RB, Chang CI, Wu IH, Lin FY. Selective medical treatment of infected aneurysms of the aorta in high risk patients. J Vasc Surg 2009; 49:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/136\">",
"      Taylor CF, Lennox AF. Treatment options for primary infected aorta. Ann Vasc Surg 2007; 21:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/137\">",
"      Ewart JM, Burke ML, Bunt TJ. Spontaneous abdominal aortic infections. Essentials of diagnosis and management. Am Surg 1983; 49:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/138\">",
"      Pasic M, von Segesser L, Turina M. Implantation of antibiotic-releasing carriers and in situ reconstruction for treatment of mycotic aneurysm. Arch Surg 1992; 127:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/139\">",
"      Koskas F, Plissonnier D, Bahnini A, et al. In situ arterial allografting for aortoiliac graft infection: a 6-year experience. Cardiovasc Surg 1996; 4:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/140\">",
"      Pasic M. Mycotic aneurysm of the aorta: evolving surgical concept. Ann Thorac Surg 1996; 61:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/141\">",
"      Pasic M, Carrel T, von Segesser L, Turina M. In situ repair of mycotic aneurysm of the ascending aorta. J Thorac Cardiovasc Surg 1993; 105:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/142\">",
"      von Segesser LK, Vogt P, Genoni M, et al. The infected aorta. J Card Surg 1997; 12:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/143\">",
"      Lee CH, Hsieh HC, Ko PJ, et al. In situ versus extra-anatomic reconstruction for primary infected infrarenal abdominal aortic aneurysms. J Vasc Surg 2011; 54:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/144\">",
"      Bandyk DF, Novotney ML, Johnson BL, et al. Use of rifampin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections. J Surg Res 2001; 95:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/145\">",
"      Schneider JR, Oskin SI, Verta MJ Jr. Superficial femoral vein graft interposition in situ repair for femoral mycotic aneurysm. Ann Vasc Surg 2009; 23:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/146\">",
"      Benjamin ME, Cohn EJ Jr, Purtill WA, et al. Arterial reconstruction with deep leg veins for the treatment of mycotic aneurysms. J Vasc Surg 1999; 30:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/147\">",
"      Vogt PR, Brunner-LaRocca HP, Lachat M, et al. Technical details with the use of cryopreserved arterial allografts for aortic infection: influence on early and midterm mortality. J Vasc Surg 2002; 35:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/148\">",
"      Noel AA, Gloviczki P, Cherry KJ Jr, et al. Abdominal aortic reconstruction in infected fields: early results of the United States cryopreserved aortic allograft registry. J Vasc Surg 2002; 35:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/149\">",
"      Kerzmann A, Ausselet N, Daenen G, Linder JL. Infected abdominal aortic aneurysm treated by in situ replacement with cryopreserved arterial homograft. Acta Chir Belg 2006; 106:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/150\">",
"      Bisdas T, Bredt M, Pichlmaier M, et al. Eight-year experience with cryopreserved arterial homografts for the in situ reconstruction of abdominal aortic infections. J Vasc Surg 2010; 52:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/151\">",
"      Brown KE, Heyer K, Rodriguez H, et al. Arterial reconstruction with cryopreserved human allografts in the setting of infection: A single-center experience with midterm follow-up. J Vasc Surg 2009; 49:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/152\">",
"      McCready RA, Bryant MA, Divelbiss JL, et al. Arterial infections in the new millenium: an old problem revisited. Ann Vasc Surg 2006; 20:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/153\">",
"      Landry GJ, Carlson JR, Liem TK, et al. The sartorius muscle flap: an important adjunct for complicated femoral wounds involving vascular grafts. Am J Surg 2009; 197:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/154\">",
"      Inoue H, Iguro Y, Yamamoto H, et al. Palliative stent-graft insertion followed by an allograft replacement for an infected and ruptured aortic aneurysm. Ann Thorac Cardiovasc Surg 2009; 15:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/155\">",
"      Mofidi R, Bhat R, Nagy J, et al. Endovascular repair of a ruptured mycotic aneurysm of the common iliac artery. Cardiovasc Intervent Radiol 2007; 30:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/156\">",
"      Klonaris C, Katsargyris A, Matthaiou A, et al. Emergency stenting of a ruptured infected anastomotic femoral pseudoaneurysm. Cardiovasc Intervent Radiol 2007; 30:1238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/157\">",
"      Trellopoulos G, Georgiadis GS, Kapoulas KC, et al. Emergency endovascular treatment of early spontaneous nonaneurysmal popliteal artery rupture in a patient with Salmonella bacteremia. J Vasc Surg 2010; 52:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/158\">",
"      Klonaris C, Katsargyris A, Vasileiou I, et al. Hybrid repair of ruptured infected anastomotic femoral pseudoaneurysms: Emergent stent-graft implantation and secondary surgical debridement. J Vasc Surg 2009; 49:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/159\">",
"      Araki T, Ogane K. Images in cardiovascular medicine. Rupture of infected splenic artery aneurysm secondary to infective endocarditis. Circulation 2008; 118:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/160\">",
"      Dogan S, Memis A, Kale A, Buket S. Endovascular stent graft placement in the treatment of ruptured tuberculous pseudoaneurysm of the descending thoracic aorta: case report and review of the literature. Cardiovasc Intervent Radiol 2009; 32:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/161\">",
"      Kische S, Ince H, Peuster M. Coil occlusion of a subclavian mycotic aneurysm. Catheter Cardiovasc Interv 2010; 75:1116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/162\">",
"      Bush RL, Hurt JE, Bianco CC. Endovascular management of a ruptured mycotic aneurysm of the innominate artery. Ann Thorac Surg 2002; 74:2184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/163\">",
"      Patel HJ, Williams DM, Upchurch GR Jr, et al. Late outcomes of endovascular aortic repair for the infected thoracic aorta. Ann Thorac Surg 2009; 87:1366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/164\">",
"      Stanley BM, Semmens JB, Lawrence-Brown MM, et al. Endoluminal repair of mycotic thoracic aneurysms. J Endovasc Ther 2003; 10:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/165\">",
"      Patel HJ, Williams DM, Upchurch GR Jr, et al. Thoracic aortic endovascular repair for mycotic aneurysms and fistulas. J Vasc Surg 2010; 52:37S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/166\">",
"      Kpodonu J, Williams JP, Ramaiah VG, Diethrich EB. Endovascular management of a descending thoracic mycotic aneurysm: mid-term follow-up. Eur J Cardiothorac Surg 2007; 32:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/167\">",
"      Ugurlucan M, Alpagut U. Endoluminal stenting of thoracic aorta mycotic aneurysms. Eur J Cardiothorac Surg 2007; 32:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/168\">",
"      Razavi MK, Razavi MD. Stent-graft treatment of mycotic aneurysms: a review of the current literature. J Vasc Interv Radiol 2008; 19:S51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/169\">",
"      Gonz&aacute;lez-Fajardo JA, Guti&eacute;rrez V, Mart&iacute;n-Pedrosa M, et al. Endovascular repair in the presence of aortic infection. Ann Vasc Surg 2005; 19:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/170\">",
"      Clough RE, Black SA, Lyons OT, et al. Is endovascular repair of mycotic aortic aneurysms a durable treatment option? Eur J Vasc Endovasc Surg 2009; 37:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/171\">",
"      Jones HR Jr, Siekert RG. Neurological manifestations of infective endocarditis. Review of clinical and therapeutic challenges. Brain 1989; 112 ( Pt 5):1295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/172\">",
"      Peters PJ, Harrison T, Lennox JL. A dangerous dilemma: management of infectious intracranial aneurysms complicating endocarditis. Lancet Infect Dis 2006; 6:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/173\">",
"      Ducruet AF, Hickman ZL, Zacharia BE, et al. Intracranial infectious aneurysms: a comprehensive review. Neurosurg Rev 2010; 33:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/174\">",
"      Frizzell RT, Vitek JJ, Hill DL, Fisher WS 3rd. Treatment of a bacterial (mycotic) intracranial aneurysm using an endovascular approach. Neurosurgery 1993; 32:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/175\">",
"      Yen PS, Teo BT, Chen SC, Chiu TL. Endovascular treatment for bilateral mycotic intracavernous carotid aneurysms. Case report and review of the literature. J Neurosurg 2007; 107:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/176\">",
"      Dhomne S, Rao C, Shrivastava M, et al. Endovascular management of ruptured cerebral mycotic aneurysms. Br J Neurosurg 2008; 22:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/177\">",
"      Lopes RJ, Almeida J, Dias PJ, et al. Infectious thoracic aortitis: a literature review. Clin Cardiol 2009; 32:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/178\">",
"      Ando Y, Kurisu K, Hisahara M, et al. Multiple infected aortic aneurysms repaired by staged in situ graft replacement. Ann Thorac Cardiovasc Surg 2010; 16:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/179\">",
"      Nakashima M, Usui A, Oshima H, Ueda Y. The treatment of infectious aneurysms in the thoracic aorta; our experience in treating five consecutive patients. Interact Cardiovasc Thorac Surg 2010; 10:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/180\">",
"      Hsu RB, Lin FY. Infected aneurysm of the thoracic aorta. J Vasc Surg 2008; 47:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/181\">",
"      Hsu RB, Lin FY. Surgery for infected aneurysm of the aortic arch. J Thorac Cardiovasc Surg 2007; 134:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/182\">",
"      Nishimura Y, Okamura Y, Hiramatsu T, et al. Successful in situ treatment of infected aortic arch prosthesis by omental wrapping. Asian Cardiovasc Thorac Ann 2006; 14:e93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/183\">",
"      Sakaki M, Takano H, Miyamoto Y, et al. Graft replacement and muscle wrap for infected aneurysm of thoracic aorta. Asian Cardiovasc Thorac Ann 2006; 14:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/184\">",
"      Weis-M&uuml;ller BT, Rascanu C, Sagban A, et al. Single-center experience with open surgical treatment of 36 infected aneurysms of the thoracic, thoracoabdominal, and abdominal aorta. Ann Vasc Surg 2011; 25:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/185\">",
"      Le&oacute;n LR, Mills JL. Diagnosis and management of mycotic aneurysms. Curr Infect Dis Rep 2009; 11:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/186\">",
"      Leon LR Jr, Mills JL Sr. Diagnosis and management of aortic mycotic aneurysms. Vasc Endovascular Surg 2010; 44:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/187\">",
"      Dubois M, Daenens K, Houthoofd S, et al. Treatment of mycotic aneurysms with involvement of the abdominal aorta: single-centre experience in 44 consecutive cases. Eur J Vasc Endovasc Surg 2010; 40:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/188\">",
"      Woon CY, Sebastian MG, Tay KH, Tan SG. Extra-anatomic revascularization and aortic exclusion for mycotic aneurysms of the infrarenal aorta and iliac arteries in an Asian population. Am J Surg 2008; 195:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/189\">",
"      Ali AT, Modrall JG, Hocking J, et al. Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts. J Vasc Surg 2009; 50:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/190\">",
"      Hagendoorn J, de Vries JP, Moll FL. Primary infected, ruptured abdominal aortic aneurysms: what we learned in 10 years. Vasc Endovascular Surg 2010; 44:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/191\">",
"      Atnip RG. Mycotic aneurysms of the suprarenal abdominal aorta: prolonged survival after in situ aortic and visceral reconstruction. J Vasc Surg 1989; 10:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/192\">",
"      van Dam van Isselt EF, Moll FL, Bast TJ. Cryptogenic Salmonella-infected ruptured aortic aneurysms. Cardiovasc Surg 1998; 6:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/193\">",
"      Khalil I, Nawfal G. Mycotic aneurysms of the carotid artery: ligation vs. reconstruction--case report and review of the literature. Eur J Vasc Surg 1993; 7:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/194\">",
"      Zhang Q, Duan ZQ, Xin SJ, et al. Management of extracranial carotid artery aneurysms: 17 years' experience. Eur J Vasc Endovasc Surg 1999; 18:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/195\">",
"      O'Connell JB, Darcy S, Reil T. Extracranial internal carotid artery mycotic aneurysm: case report and review. Vasc Endovascular Surg 2009; 43:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/196\">",
"      Abularrage CJ, Crawford RS, Durand ML, LaMuraglia GM. Extracranial infected carotid artery aneurysm. J Vasc Surg 2009; 50:1484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/197\">",
"      Wales L, Kruger AJ, Jenkins JS, et al. Mycotic carotid pseudoaneurysm: staged endovascular and surgical repair. Eur J Vasc Endovasc Surg 2010; 39:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/198\">",
"      Albayrak R, Saglam H, Emmiler M, et al. Large mycotic aneurysm of the peroneal artery. J Clin Ultrasound 2007; 35:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/199\">",
"      Hu ZJ, Wang SM, Li XX, et al. Tolerable hemodynamic changes after femoral artery ligation for the treatment of infected femoral artery pseudoaneurysm. Ann Vasc Surg 2010; 24:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/200\">",
"      Mousavi SR, Saberi A, Tadayon N, et al. Femoral artery ligation as treatment for infected pseudo-aneurysms, secondary to drug injection. Acta Chir Belg 2010; 110:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/201\">",
"      Ehsan O, Gibbons CP. A 10-year experience of using femoro-popliteal vein for re-vascularisation in graft and arterial infections. Eur J Vasc Endovasc Surg 2009; 38:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/202\">",
"      Scavee V, Vranckx P, Pauls C, et al. Femoral bifurcation infected pseudoaneurysm: a simple and quick arterial reconstruction with reversed bifurcated saphenous vein graft. Int Angiol 2009; 28:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/203\">",
"      Chan YC, Burnand KG. Management of septic groin complications and infected femoral false aneurysms in intravenous drug abusers. Br J Surg 2006; 93:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/204\">",
"      Salimi J, Shojaeefar A, Khashayar P. Management of infected femoral pseudoaneurysms in intravenous drug abusers: a review of 57 cases. Arch Med Res 2008; 39:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/205\">",
"      Coughlin PA, Mavor AI. Arterial consequences of recreational drug use. Eur J Vasc Endovasc Surg 2006; 32:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/206\">",
"      Tan KK, Chen K, Chia KH, et al. Surgical management of infected pseudoaneurysms in intravenous drug abusers: single institution experience and a proposed algorithm. World J Surg 2009; 33:1830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/207\">",
"      Salimi J. On the management of mycotic femoral pseudoaneurysms in intravenous drug abusers. Ann Vasc Surg 2009; 23:824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/208\">",
"      Peirce C, Coffey JC, O'Grady H, et al. The management of mycotic femoral pseudoaneurysms in intravenous drug abusers. Ann Vasc Surg 2009; 23:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/209\">",
"      Yegane RA, Salehi NA, Ghaseminegad A, et al. Surgical approach to vascular complications of intravenous drug abuse. Eur J Vasc Endovasc Surg 2006; 32:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/210\">",
"      Klonaris C, Katsargyris A, Papapetrou A, et al. Infected femoral artery pseudoaneurysm in drug addicts: the beneficial use of the internal iliac artery for arterial reconstruction. J Vasc Surg 2007; 45:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/211\">",
"      Schimmer W, Somjen GM. Endovascular repair of a ruptured, mycotic popliteal aneurysm. ANZ J Surg 2009; 79:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/212\">",
"      Funk LM, Robinson WP, Menard MT. Surgical treatment of an infected popliteal artery aneurysm 12 years after aneurysm exclusion and bypass. Ann Vasc Surg 2010; 24:553.e9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/213\">",
"      Lai KM, Rosenthal D, Wellons ED, et al. Mycotic superior mesenteric aneurysm. J Vasc Surg 2007; 45:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/214\">",
"      McCready RA, Bryant MA, Fehrenbacher JW, Rowe MG. Infected splenic artery aneurysm with associated splenic abscess formation secondary to bacterial endocarditis: case report and review of the literature. J Vasc Surg 2007; 45:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/215\">",
"      D&iacute;az E, Lozano FS, Gonz&aacute;lez S, et al. Open and endovascular treatment for pseudoaneurysms of the superior mesenteric artery. Ann Vasc Surg 2010; 24:690.e9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/17/35098/abstract/216\">",
"      Leon LR, Psalms SB, Labropoulos N, Mills JL. Infected upper extremity aneurysms: a review. Eur J Vasc Endovasc Surg 2008; 35:320.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2129 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-88.81.100.162-2094B74F85-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_17_35098=[""].join("\n");
var outline_f34_17_35098=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13204212\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8521624\">",
"      Pre-existing aneurysm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20047087\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20047200\">",
"      Direct bacterial inoculation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20047212\">",
"      Bacteremic seeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20047224\">",
"      Contiguous infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20046986\">",
"      Septic emboli (mycotic aneurysm)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1118580\">",
"      Other manifestations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20047525\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3895948\">",
"      - Infected versus inflammatory aneurysm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1118621\">",
"      Antibiotic therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8508712\">",
"      - Aneurysm excision and ligation without arterial reconstruction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8508726\">",
"      - Excision with immediate reconstruction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8508733\">",
"      - Excision with interval reconstruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20046089\">",
"      Role of endovascular techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1118677\">",
"      SPECIFIC ANATOMIC SITES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8476368\">",
"      Intracranial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8476375\">",
"      Thoracic aorta",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8510679\">",
"      Abdominal aorta and iliac arteries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8476382\">",
"      Extracranial carotid artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8476403\">",
"      Lower extremity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8476389\">",
"      Visceral arteries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8476396\">",
"      Upper extremity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13204212\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/2129\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2129|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?25/60/26566\" title=\"figure 1\">",
"      Collateral circulation lower extremity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?18/1/18454\" title=\"figure 2\">",
"      Collateral circulation around the shoulder",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/3/13368?source=related_link\">",
"      Acute arterial occlusion of the lower extremities (acute limb ischemia)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/21/44377?source=related_link\">",
"      Acute mesenteric ischemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/27/40378?source=related_link\">",
"      Carotid endarterectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/27/33206?source=related_link\">",
"      Chronic mesenteric ischemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/16/32010?source=related_link\">",
"      Clinical features and diagnosis of abdominal aortic aneurysm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/47/9978?source=related_link\">",
"      High-output heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/39/29304?source=related_link\">",
"      Iliac artery aneurysm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/7/10361?source=related_link\">",
"      Management and outcome of thoracic aortic aneurysm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38746?source=related_link\">",
"      Management of asymptomatic abdominal aortic aneurysm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/61/11225?source=related_link\">",
"      Management of symptomatic (non-ruptured) and ruptured abdominal aortic aneurysm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30454?source=related_link\">",
"      Massive hemoptysis: Initial management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/16/10506?source=related_link\">",
"      Noninvasive diagnosis of arterial disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/15/42233?source=related_link\">",
"      Overview of lower extremity peripheral nerve syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/44/8906?source=related_link\">",
"      Overview of upper extremity peripheral nerve syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/63/3065?source=related_link\">",
"      Popliteal artery aneurysm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/58/19370?source=related_link\">",
"      Treatment of chronic lower extremity critical limb ischemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/40/25225?source=related_link\">",
"      Unruptured intracranial aneurysms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/28/22985?source=related_link\">",
"      Vertebral osteomyelitis and discitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_17_35099="Patch test interpretation";
var content_f34_17_35099=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F65159&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F65159&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Interpretation of patch test reactions",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Score",
"       </td>",
"       <td class=\"subtitle1\">",
"        Interpretation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Tips and advice",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        Negative reaction",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        ? or +/-",
"       </td>",
"       <td>",
"        Doubtful reaction, faint erythema",
"       </td>",
"       <td>",
"        Caution with interpretation, especially with less common allergens. Consider repeat testing or follow-up with ROAT testing.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        Weak reaction, erythema, slight infiltration",
"       </td>",
"       <td>",
"        Erythema should be palpable and occupy &gt;50 percent of patch test site.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        Strong reaction, erythema, infiltration, vesicles",
"       </td>",
"       <td>",
"        Look for microvesicles to occupy at least 50 percent of the patch test site.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        Extreme, bullous, ulcerative",
"       </td>",
"       <td>",
"        Confluent vesicles.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IR",
"       </td>",
"       <td>",
"        Irritant reactions",
"       </td>",
"       <td>",
"        There is a broad range. Mild irritant reactions have a glazed appearance. Moderate reactions are follicular (pustular in atopics). Extreme reactions can be ulcerative.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        NT",
"       </td>",
"       <td>",
"        Not tested",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_17_35099=[""].join("\n");
var outline_f34_17_35099=null;
var title_f34_17_35100="Eval risk factor CHD DM I";
var content_f34_17_35100=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F63757&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F63757&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Evaluation of major risk factors for coronary heart disease in patients with diabetes mellitus",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Cigarette smoking",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        History:",
"       </strong>",
"       Record current and past smoking habits; list smoking duration (years of use) and intensity (number of cigarettes smoked per day); determine passive smoke exposure (at work and at home).",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Blood pressure",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        History:",
"       </strong>",
"       Record history of blood pressure (BP) and measures of treatment, including current and past antihypertensive drug therapy. Also determine acquired factors affecting BP: body weight, physical activity level, sodium intake, and alcohol consumption.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Physical examination:",
"       </strong>",
"       Define current BP from multiple measurements; measure BP supine, sitting, and standing in elderly patients; consider 24-hour automated, ambulatory BP monitoring in older patients (detects absence of nocturnal fall in BP [autonomic dysfunction], episodic hypertension, orthostatic hypertension, resistant hypertension).",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Serum lipids and lipoproteins",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        History:",
"       </strong>",
"       Assess dietary habits and alcohol intake, exercise habits, efforts to modify lifestyle habits, use of medications that influence serum lipoprotein values, family history of premature vascular disease and dyslipidemia, history of thyroid disorders or pancreatitis.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Physical examination:",
"       </strong>",
"       Check for eruptive xanthomas and lipemia retinalis (signs of severe hypertriglyceridemia), tuberoeruptive xanthomas (sign of dysbetalipoproteinemia), xanthelasma (suggestive of hyperlipidemia), and signs of hypothyroidism.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Laboratory:",
"       </strong>",
"       Measure fasting serum total cholesterol, LDL cholesterol, HDLcholesterol, triglycerides; (optional: apolipoprotein B*, lipoprotein[a], LDL size), thyroid, renal, liver function tests.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Albuminuria",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Measure serum creatinine.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Test urine for protein with a dipstick: If dipstick is negative, measure urine albumin-to-creatinine ratio in the first-morning urine specimen.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Glycemic status",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        History:",
"       </strong>",
"       Age of onset of hyperglycemia; course of diabetes treatment; family history of diabetes, history of diabetic complications.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Physical examination:",
"       </strong>",
"       Cardiovascular status, retinopathy, other diabetic complications.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Laboratory:",
"       </strong>",
"       Measure fasting blood glucose; hemoglobin A1c (periodically).",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Apolipoprotein B is especially useful if triglycerides are elevated but LDL cholesterol is in the normal range.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Grundy, SM, Benjamin, IJ, Burke, GL, et al. Circulation 1999; 100:1134.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_17_35100=[""].join("\n");
var outline_f34_17_35100=null;
var title_f34_17_35101="Genetic classification of CMD";
var content_f34_17_35101=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F67132&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F67132&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Genetic classification of congenital muscular dystrophies",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Disease/phenotypes",
"       </td>",
"       <td class=\"subtitle1\">",
"        Designation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Gene location",
"       </td>",
"       <td class=\"subtitle1\">",
"        Gene",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Protein defects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Primary merosin deficiency",
"       </td>",
"       <td>",
"        MDC1A",
"       </td>",
"       <td>",
"        6q22-q23",
"       </td>",
"       <td>",
"        LAMA2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Secondary merosin deficiency",
"       </td>",
"       <td>",
"        MDC1B",
"       </td>",
"       <td>",
"        1q42",
"       </td>",
"       <td>",
"        ?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rigid spine syndrome (rigid spine muscular dystrophy 1)",
"       </td>",
"       <td>",
"        RSMD1",
"       </td>",
"       <td>",
"        1p35-p36",
"       </td>",
"       <td>",
"        SEPN1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"3\">",
"        Ullrich muscular dystrophy and Bethlem myopathy",
"       </td>",
"       <td rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"       <td>",
"        21q22.3",
"       </td>",
"       <td>",
"        COL6A1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        21q22.3",
"       </td>",
"       <td>",
"        COL6A2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2q37",
"       </td>",
"       <td>",
"        COL6A3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lamin A-related congenital muscular dystrophy",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1q21.2",
"       </td>",
"       <td>",
"        LMNA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Dystroglycanopathies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\">",
"        Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies (type A)",
"       </td>",
"       <td class=\"subtitle3_left\" colspan=\"3\">",
"        MDDGA series",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        POMT1-related Walker-Warburg syndrome and muscle-eye-brain disease",
"       </td>",
"       <td class=\"indent2\">",
"        MDDGA1",
"       </td>",
"       <td>",
"        9q34.1",
"       </td>",
"       <td>",
"        POMT1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        POMT2-related Walker-Warburg syndrome and muscle-eye-brain disease",
"       </td>",
"       <td class=\"indent2\">",
"        MDDGA2",
"       </td>",
"       <td>",
"        14q24.3",
"       </td>",
"       <td>",
"        POMT2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        POMGNT1-related muscle-eye-brain disease and Walker-Warburg syndrome",
"       </td>",
"       <td class=\"indent2\">",
"        MDDGA3",
"       </td>",
"       <td>",
"        1p34-p33",
"       </td>",
"       <td>",
"        POMGNT1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        FKTN-related Fukuyama congenital muscular dystrophy and Walker-Warburg syndrome",
"       </td>",
"       <td class=\"indent2\">",
"        MDDGA4",
"       </td>",
"       <td>",
"        9q31-q33",
"       </td>",
"       <td>",
"        FKTN",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        FKRP-related Walker-Warburg syndrome and muscle-eye-brain disease",
"       </td>",
"       <td class=\"indent2\">",
"        MDDGA5",
"       </td>",
"       <td>",
"        19q13.32",
"       </td>",
"       <td>",
"        FKRP",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        LARGE-related Walker-Warburg syndrome and muscle-eye-brain disease",
"       </td>",
"       <td class=\"indent2\">",
"        MDDGA6",
"       </td>",
"       <td>",
"        22q12.3-q13.1",
"       </td>",
"       <td>",
"        LARGE",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        ISPD-related Walker-Warburg syndrome and muscle-eye-brain disease",
"       </td>",
"       <td class=\"indent2\">",
"        MDDGA7",
"       </td>",
"       <td>",
"        7p21.2",
"       </td>",
"       <td>",
"        ISPD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        GTDC2-related Walker-Warburg syndrome and muscle-eye-brain disease",
"       </td>",
"       <td class=\"indent2\">",
"        MDDGA8",
"       </td>",
"       <td>",
"        3p22.1",
"       </td>",
"       <td>",
"        GTDC2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\">",
"        Congenital muscular dystrophy-dystroglycanopathy with or without mental retardation (type B)",
"       </td>",
"       <td class=\"subtitle3_left\" colspan=\"3\">",
"        MDDGB series",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        POMT1-related",
"       </td>",
"       <td class=\"indent2\">",
"        MDDGB1",
"       </td>",
"       <td>",
"        9q34.1",
"       </td>",
"       <td>",
"        POMT1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        POMT2-related",
"       </td>",
"       <td class=\"indent2\">",
"        MDDGB2",
"       </td>",
"       <td>",
"        14q24.3",
"       </td>",
"       <td>",
"        POMT2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        POMGNT1-related",
"       </td>",
"       <td class=\"indent2\">",
"        MDDGB3",
"       </td>",
"       <td>",
"        1p34-p33",
"       </td>",
"       <td>",
"        POMGNT1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        FKTN-related",
"       </td>",
"       <td class=\"indent2\">",
"        MDDGB4",
"       </td>",
"       <td>",
"        9q31-q33",
"       </td>",
"       <td>",
"        FKTN",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        FKRP-related",
"       </td>",
"       <td class=\"indent2\">",
"        MDDGB5",
"       </td>",
"       <td>",
"        19q13.32",
"       </td>",
"       <td>",
"        FKRP",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        LARGE-related",
"       </td>",
"       <td class=\"indent2\">",
"        MDDGB6",
"       </td>",
"       <td>",
"        22q12.3-q13.1",
"       </td>",
"       <td>",
"        LARGE",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      1. Jones K, North K. The congenital muscular dystrophies. In: Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach. Jones HR, De Vivo DC, Darras BT (Eds). Butterworth Heinemann, Philadelphia 2003.",
"      <br>",
"       2. Online Mendelian Inheritance in Man.",
"       <a href=\"file://www.ncbi.nlm.nih.gov/sites/entrez?db=omim\" target=\"_blank\">",
"        www.ncbi.nlm.nih.gov/sites/entrez?db=omim",
"       </a>",
"       (Accessed on January 19, 2011).",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_17_35101=[""].join("\n");
var outline_f34_17_35101=null;
var title_f34_17_35102="ESCC mgnt algorithm";
var content_f34_17_35102=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F60269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F60269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 567px\">",
"   <div class=\"ttl\">",
"    Suggested algorithm for the management of epidural spinal cord compression (ESCC)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 547px; height: 388px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     SRS: stereotactic radiosurgery; EBRT: external beam radiation therapy.",
"     <br>",
"      * Eg, germ cell cancer, lymphoma, neuroblastoma.",
"      <br>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       High grade ESCC is defined as compression of the spinal cord or deformation of the thecal sac with spinal cord abutment but no compression.",
"       <br>",
"        &Delta; SRS is preferred, particularly in patients with a relatively long predicted longevity (&gt;6 months).",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_17_35102=[""].join("\n");
var outline_f34_17_35102=null;
var title_f34_17_35103="Post fixation spinal TB";
var content_f34_17_35103=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F86254&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F86254&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Post-surgical drainage and fixation of spinal tuberculosis (Pott disease)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 267px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Plain film of 17-year-old fisherman&nbsp;following surgical drainage and spinal fixation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Malcolm McDonald, PhD, FRACP, FRCPA.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_17_35103=[""].join("\n");
var outline_f34_17_35103=null;
